Home
  >  
Section 9

EurekaMag Full Text Articles Chapter 8,505



References:

Tsacas, L.; Chassagnard, M.-Therese 1995: Drosophila plagiata Bezzi, a member of the melanogaster group (Diptera, Drosophilidae). Revue Francaise d'Entomologie 17(1): 19-22
Zink, D.; Paro, R. 1995: Drosophila Polycomb-group regulated chromatin inhibits the accessibility of a trans-activator to its target DNA. EMBO Journal 14(22): 5660-5671
Seelig, A.; Multhaup, G.; Pesold-Hurt, B.; Beyreuther, K.; Kloetzel, P.M. 1993: Drosophila proteasome Dm25 subunit substitutes the mouse MC3 subunit in hybrid proteasomes. The N-terminal domain is essential for subunit incorporation. Journal of Biological Chemistry 268(34): 25561-25567
Mann, D.J.; Dombrádi, V.; Cohen, P.T. 1993: Drosophila protein phosphatase V functionally complements a SIT4 mutant in Saccharomyces cerevisiae and its amino-terminal region can confer this complementation to a heterologous phosphatase catalytic domain. EMBO Journal 12(12): 4833-4842
Masai, I.; Okazaki, A.; Hosoya, T.; Hotta, Y. 1993: Drosophila retinal degeneration A gene encodes an eye-specific diacylglycerol kinase with cysteine-rich zinc-finger motifs and ankyrin repeats. Proceedings of the National Academy of Sciences of the United States of America 90(23): 11157-11161
Ntwasa, M.; Buchanan, S.G.; Gay, N.J. 1994: Drosophila ribosomal protein L18a: cDNA sequence, expression and chromosomal localization of the gene. Biochimica et Biophysica Acta 1218(2): 210-212
Yacoub, A.; Kelley, M.R.; Deutsch, W.A. 1996: Drosophila ribosomal protein PO contains apurinic/apyrimidinic endonuclease activity. Nucleic Acids Research 24(21): 4298-4303
Wilson, D.M.; Deutsch, W.A.; Kelley, M.R. 1994: Drosophila ribosomal protein S3 contains an activity that cleaves DNA at apurinic/apyrimidinic sites. Journal of Biological Chemistry 269(41): 25359-25364
Lawrence, P.A.; Sampedro, J. 1993: Drosophila segmentation: after the first three hours. Development 119(4): 971-976
Galli, A.; Petersen, C.I.; deBlaquiere, M.; Blakely, R.D.; DeFelice, L.J. 1997: Drosophila serotonin transporters have voltage-dependent uptake coupled to a serotonin-gated ion channel. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 17(10): 3401-3411
Schmidt, J.; Francois, V.; Bier, E.; Kimelman, D. 1995: Drosophila short gastrulation induces an ectopic axis in Xenopus: evidence for conserved mechanisms of dorsal-ventral patterning. Development 121(12): 4319-4328
Cant, K.; Knowles, B.A.; Mooseker, M.S.; Cooley, L. 1994: Drosophila singed, a fascin homolog, is required for actin bundle formation during oogenesis and bristle extension. Journal of cell biology 125(2): 369-380
Benado, M.; Klein, E.; Brncic, D. 1995: Drosophila subobscura in central Chile: Long-term trends in the abundance series of the Drosophilid community La Florida, 1984-1991. Evolucion Biologica (Bogota) 8-9: 49-59
Shishido, E.; Takeichi, M.; Nose, A. 1998: Drosophila synapse formation: Regulation by transmembrane protein with leu-rich repeats, CAPRICIOUS. Science 280(5372): 2118-2121
Spring, J.; Paine-Saunders, S.E.; Hynes, R.O.; Bernfield, M. 1994: Drosophila syndecan: conservation of a cell-surface heparan sulfate proteoglycan. Proceedings of the National Academy of Sciences of the United States of America 91(8): 3334-3338
Schulze, K.L.; Bellen, H.J. 1996: Drosophila syntaxin is required for cell viability and may function in membrane formation and stabilization. Genetics 144(4): 1713-1724
Danilevskaya, O.N.; Slot, F.; Traverse, K.L.; Hogan, N.C.; Pardue, M.L. 1994: Drosophila telomere transposon HeT-A produces a transcript with tightly bound protein. Proceedings of the National Academy of Sciences of the United States of America 91(14): 6679-6682
Cleghon, V.; Gayko, U.; Copeland, T.D.; Perkins, L.A.; Perrimon, N.; Morrison, D.K. 1996: Drosophila terminal structure development is regulated by the compensatory activities of positive and negative phosphotyrosine signaling sites on the Torso RTK. Genes and Development 10(5): 566-577
Collier, S.; Gubb, D. 1997: Drosophila tissue polarity requires the cell-autonomous activity of the fuzzy gene, which encodes a novel transmembrane protein. Development 124(20): 4029-4037
Attardi, L.D.; Tjian, R. 1993: Drosophila tissue-specific transcription factor NTF-1 contains a novel isoleucine-rich activation motif. Genes and Development 7(7b): 1341-1353
Talbot, W.S.; Swyryd, E.A.; Hogness, D.S. 1993: Drosophila tissues with different metamorphic responses to ecdysone express different ecdysone receptor isoforms. Cell 73(7): 1323-1337
Sampath, T.K.; Rashka, K.E.; Doctor, J.S.; Tucker, R.F.; Hoffmann, F.M. 1993: Drosophila transforming growth factor beta superfamily proteins induce endochondral bone formation in mammals. Proceedings of the National Academy of Sciences of the United States of America 90(13): 6004-6008
Yao, T.P.; Segraves, W.A.; Oro, A.E.; McKeown, M.; Evans, R.M. 1992: Drosophila ultraspiracle modulates ecdysone receptor function via heterodimer formation. Cell 71(1): 63-72
Gubenko, I.S.; Subbota, R.P.; Khripunov, V.A.; Vagin, Y., V. 1995: Drosophila virilis linkage map revision: Cytological localization of Delta and ebony loci. Dopovidi Natsional'noyi Akademiyi Nauk Ukrayiny 1995(4): 126-129
Webster, P.J.; Suen, J.; Macdonald, P.M. 1994: Drosophila virilis oskar transgenes direct body patterning but not pole cell formation or maintenance of mRNA localization in D. melanogaster. Development 120(7): 2027-2037
Regner, L., P.; Valente, V.-Lucia, S. 1993: Drosophila willistoni mating activity: Urbanization effects and a search for its chromosomal basis. Evolucion Biologica 7: 327-349
Vincent, J.P.; Lawrence, P.A. 1994: Drosophila wingless sustains engrailed expression only in adjoining cells: Evidence from mosaic embryos. Cell 77(6): 909-915
Banfi, S.; Borsani, G.; Bulfone, A.; Ballabio, A. 1997: Drosophila-related expressed sequences. Human Molecular Genetics 6(10): 1745-1753
Singh, BK.; Dash, S. 1993: Drosophilidae of Uttarakhand region with the description of one new species (Insecta: Diptera). Proceedings of the Zoological Society 46(2): 131-140
Ursu, A. 1992: Drosophilids and sphaerocerids (Diptera) in the fauna of Romania: III. Travaux du Museum National d'Histoire Naturelle "Grigore Antipa" 32: 211-215
Imasheva, A.G.; Lazebny, O.E.; Cariou, M.L.; David, J.R.; Tsacas, L. 1994: Drosophilids from Daghestan (Russia) with description of a new species (Diptera). Annales de la Societe Entomologique de France 30(2): 209-216
Muhn, P.; Krattenmacher, R.; Beier, S.; Elger, W.; Schillinger, E. 1995: Drospirenone: A novel progestogen with antimineralocorticoid and antiandrogenic activity. Pharmacological characterization in animal models. Contraception 51(2): 99-110
Delgado, O.; Rodriguez-Prieto, C.; Frigola-Girones, L.; Ballesteros, E. 1995: Drought Tolerance and Light Requirements of High and Low Sublittoral Species of Mediterranean Macroalgae of the Genus Cystoseira C. Agardh (Fucales, Phaeophyceae). Botanica Marina 38(2): 127-132
Launois, M. 1996: Drought adaptations of a wingless acridid in the Brazilian Nordeste. Secheresse 7(2): 99-103
Shmat'ko, I.G.; Shvedova, O.E.; Latashenko, O.P.; Shevchenko, N.A.; Pankova, L.M.; Semikhodski, A.G. 1995: Drought aftereffects in the period of heading-flowering on the water regime and formation of the winter wheat yield structure. Fiziologiya i Biokhimiya Kul'turnykh Rastenii 27(1-2): 93-98
Bootsma, A.; Boisvert, J., B.; De-Jong, R.; Baier, W. 1996: Drought and Canadian agriculture: A review of proposed remedies. Secheresse 7(4): 277-285
Mainguet, M.; Letolle, R.; Glazowski, N. 1995: Drought and aridity in the Aralo-Caspienne. Secheresse 6(1): 135-143
Jefferies, R.A. 1994: Drought and chlorophyll fluorescence in field-grown potato (Solanum tuberosum). Physiologia Plantarum 90(1): 93-97
Orlovskii, N.S. 1994: Drought and desertification: Possible forecast. Problemy Osvoeniya Pustyn' 1994(4-5): 106-123
Ramampiherika, K.D.; Ralijaona, C.G. 1995: Drought and drinking water in Madagascar. Secheresse 6(1): 119-121
Launois, M.; Launois Luong, M.H.; Lecoq, M. 1996: Drought and grasshopper survival in the West-African Sahel. Secheresse 7(2): 119-127
Liu, Z.; Wang, Q.C.; Wang, H.C.; Zheng, Z. 1996: Drought and locust plagues in China: The case of Locusta migratoria manilensis (Meyen). Secheresse 7(2): 105-108
Nagy, Z.; Galiba, G. 1995: Drought and salt tolerance are not necessarily linked: A study on wheat varieties differing in drought tolerance under consecutive water and salinity stresses. Journal of Plant Physiology 145(1-2): 168-174
Yoon, J.T.; Lim, J.H.; Choi, D.J.; Kim, H.K.; Choi, B.S.; Yeo, S.K. 1996: Drought damages on hot pepper in Kyungbuk District during 1994 dry spell. RDA Journal of Agricultural Science Horticulture 38(1): 558-562
Khristovaya, T.E.; Musienko, N.N.; Kazakov, E.A. 1995: Drought effect on the growth and development of maize stem. Fiziologiya i Biokhimiya Kul'turnykh Rastenii 27(5-6): 395-400
Zverev, N.E. 1994: Drought effect on underground subshrub organs in the Garagum Desert. Problemy Osvoeniya Pustyn' 1994(2): 60-67
Van Iersel, M.W.; Oosterhuis, D.M. 1996: Drought effects on the water relations of cotton fruits, bracts, and leaves during ontogeny. Environmental and Experimental Botany 36(1): 51-59
Sheaffer, C.C.; Peterson, P.R.; Hall, M.H.; Stordhal, J.B. 1992: Drought effects on yield and quality of perennial grasses in the North Central United States. Journal of Production Agriculture 5(4): 556-561
Lamersdorf, N.P.; Blanck, K.; Bredemeier, M.; Xu, Y.J. 1998: Drought experiments within the solling roof project. Chemosphere 36(4-5): 1161-1166
Albouchi, A.; Ghrir, R.; El Aouni, M.H. 1997: Drought hardening, soluble carbohydrates and free amino acid accumulation in Acacia cyanophylla Lindl phyllodes. Annales des Sciences Forestieres 54(2): 155-168
Sudachkova, N.E.; Milyutina, I.L.; Kudashova, F.N.; Semenova, G.P.; Kozhevnikova, N.N. 1996: Drought impact on composition of free amino acids in Pinus sylvestris and Larix sibirica tissues. Lesovedenie 1996(3): 57-67
Squires, V.R. 1995: Drought in Australia with special reference to pastoralism: Lessons learned or experience wasted?. Secheresse 6(1): 127-134
Beltrando, G.; Camberlin, P. 1995: Drought in Ethiopia and East Africa. Secheresse 6(1): 87-94
Bovin, P. 1995: Drought in Mexico. Secheresse 6(1): 53-58
Protasov, O.I. 1996: Drought influence on cell ultrastructure of mesophyll in needles of Pinus sylvestris L. Ukrayins'kyi Botanichnyi Zhurnal 53(6): 739-742
Jamieson, P.D.; Martin, R.J.; Francis, G.S. 1995: Drought influences on grain yield of barley, wheat, and maize. New Zealand Journal of Crop and Horticultural Science 23(1): 55-66
Pollard, E.; Greatorex Davies, J.N.; Thomas, J.A. 1997: Drought reduces breeding success of the butterfly Aglais urticae. Ecological Entomology 22(3): 315-318
Carrow, R.N. 1996: Drought resistance aspects of turfgrasses in the Southeast: Root-shoot responses. Crop Science 36(3): 687-694
Dolgikh, Y.I.; Larina, S.N.; Shamina, Z.B.; Zhdanova, N.E.; Pustovoitova, T.N. 1994: Drought resistance of maize plants obtained from cell lines resistant to the osmotic effect of ethylene glycol. Fiziologiya Rastenii 41(6): 853-858
Davies, F.T. Jr.;; Potter, J.R.; Linderman, R.G. 1993: Drought resistance of mycorrhizal pepper plants independent of leaf phosphorus concentration: Response in gas exchange and water relations. Physiologia Plantarum 87(1): 45-53
Pustovoitova, T.N.; Eremin, G.V.; Rassvetaeva, E.G.; Zhdanova, N.E.; Zholkevich, V.N. 1996: Drought resistance, repair capacity and phytohormone content in polyploid plum plant leaves. Fiziologiya Rastenii 43(2): 267-271
Makela, P.; Vaarala, L.; Rajalahti, R.; Rajala, A.; Peltonen Sainio, P. 1997: Drought response of modern and old oat lines in greenhouse and long-term field trials. Agricultural and Food Science in Finland 6(2): 199-205
Vartanian, N.; Marcotte, L.; Giraudat, J. 1994: Drought rhizogenesis in Arabidopsis thaliana. Plant Physiology (Rockville) 104(2): 761-767
Hertzberg, K.; Leinaas, H.P. 1998: Drought stress as a mortality factor in two pairs of sympatric species of Collembola at Spitsbergen, Svalbard. Polar Biology. : 302-306,
Olsson, M.; Nilsson, K.; Liljenberg, C.; Hendry, G., A.F. 1996: Drought stress in seedlings: Lipid metabolism and lipid peroxidation during recovery from drought in Lotus corniculatus and Cerastium fontanum. Physiologia Plantarum 96(4): 577-584
English-Loeb, G.; Stout, M., J.; Duffey, S., S. 1997: Drought stress in tomatoes: Changes in plant chemistry and potential nonlinear consequences for insect herbivores. Oikos 79(3): 456-468
Blake, J.; Jordan, G.J. 1993: Drought tolerance and avoidance in the localised endemic Leptospermum grandiflorum and co-occurring species. Australian Systematic Botany 6(5): 559-569
Ramanjulu, S.; Sudhakar, C. 1997: Drought tolerance is partly related to amino acid accumulation and ammonia assimilation: A comparative study in two mulberry genotypes differing in drought sensitivity. Journal of Plant Physiology 150(3): 345-350
Necasek, J.; Nemcova, M.; Lisa, L.; Dusbabkova, J.; Nasinec, V.; Pozarkova, D. 1993: Drought tolerance of Rhizobium leguminosarum and Rhizobium meliloti. Folia Microbiologica 38(4): 320-324
Meher-Homji, Vispy, M. 1995: Drought, aridity and desertification:: The case of the Indian sub-continent. Secheresse 6(1): 145-155
Closs, G.P.; Lake, P.S.m 1996: Drought, differential mortality and the coexistence of a native and an introduced fish species in a south east Australian intermittent stream. Environmental Biology of Fishes 47(1): 17-26
Beerling, D.J.; Heath, J.; Woodward, F.I.; Mansfield, T.A. 1996: Drought-CO-2 interactions in trees: Observations and mechanisms. New Phytologist 134(2): 235-242
Eller, B.M.; Donatz, M.; Ferrari, S.; Ruess, B.R. 1992: Drought-induced changes in the nocturnal carbon dioxide fixation pattern of Senecio medley woodii. Botanica Helvetica 102(2): 201-209
Tyree, M., T.; Cochard, H.; Cruiziat, P.; Sinclair, B.; Ameglio, T. 1993: Drought-induced leaf shedding in walnut: Evidence for vulnerability segmentation. Plant Cell and Environment 16(7): 879-882
Sheoran, I., S.; Saini, H., S. 1996: Drought-induced male sterility in rice: Changes in carbohydrate levels and enzyme activities associated with the inhibition of starch accumulation in pollen. Sexual Plant Reproduction 9(3): 161-169
Honegger, R.; Peter, M.; Scherrer, S. 1996: Drought-induced structural alterations at the mycobiont-photobiont interface in a range of foliose macrolichens. Protoplasma 3-4: 221-232
Knight, M.H. 1995: Drought-related mortality of wildlife in the southern Kalahari and the role of man. African Journal of Ecology 33(4): 377-394
Wang, M.; Tao Dali 1998: Drought-tolerance of main tree species in Changbai Mountain. Yingyong Shengtai Xuebao 9(1): 7-10
Gillon, Y. 1996: Drought: An evil necessary for locusts?. Secheresse 7(2): 133-143
Sergeev, M.G. 1996: Droughts and distribution patterns of locust and grasshoppers in Central and North Asia. Secheresse 7(2): 129-132
Dooley, J.; Gordon, K.; Camfield, P. 1993: Drowning deaths in people with epilepsy. Cmaj: Canadian Medical Association Journal 149(3): 270
Stumpp, J.W.; Schneider, J.; Bär, W. 1997: Drowning of a girl with anomaly of the bundle of His and the right bundle branch. American Journal of Forensic Medicine and Pathology 18(2): 208-210
Hartwig, D. 1992: Drowning of wild and domestic animals in canals. Zeitschrift fuer Jagdwissenschaft 38(3): 187-194
Okabe, N.; Nakasaka, T. 1994: Drug binding properties of glycosylated bovine serum albumin as measured by circular dichroism. Biological and Pharmaceutical Bulletin 17(11): 1505-1507
Cook, W.J.; Walter, L.J.; Walter, M.R. 1994: Drug Binding by Calmodulin: Crystal Structure of a Calmodulin-Trifluoperazine Complex. Biochemistry 33(51): 15259-15265
Preston, K.L.; Bigelow, G.E. 1994: Drug discrimination assessment of agonist-antagonist opioids in humans: a three-choice saline-hydromorphone-butorphanol procedure. Journal of Pharmacology and Experimental Therapeutics 271(1): 48-60
Tomie, A.; Shultz, P.L.; Spicer, M.S.; Peoples, L.L. 1995: Drug Discrimination Training With Low Doses: Maintenance of Discriminative Control. Pharmacology Biochemistry and Behavior 50(1): 115-119
Gindin, J.; Baumgarten, M.; Ginzburg, A.; Hyman, R.; Gewanter, R.; Mitzner, L.; Superstein, R.; Tanenbaum, C. 1994: Drug Misuse in the Elderly of the Yehudah District in Israel. Einstein Quarterly Journal of Biology and Medicine 11(4): 133-144
Chutka, D.S.; Evans, J.M.; Fleming, K.C.; Mikkelson, K.G. 1995: Drug Prescribing for Elderly Patients. O Clinic Proceedings 70(7): 685-693
Yoshida, M.; Okamoto, S.; Higashi, T.; Nakamura, Y. 1994: Drug Release Behaviors from the Matrix Prepared with Psyllium Husk. Yakuzaigaku 54(4): 197-204
Malone, J.L.; Paparello, S.F.; Malone, J.D.; Hill, H.E.; Conrad, K.A.; Myers, J.W.; Lillibridge, S.R.; Weiss, P.J. 1994: Drug susceptibility of Mycobacterium tuberculosis isolates from recent Haitian migrants: correlation with clinical response. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 19(5): 938-940
Lee, K.R.; Leggiadro, R.J.; Burch, K.J. 1994: Drug use evaluation of antibiotics in a pediatric teaching hospital. Infection Control and Hospital Epidemiology 15(11): 710-712
Kimura, T.; Sudo, K.; Kanzaki, Y.; Miki, K.; Takeichi, Y.; Kurosaki, Y.; Nakayama, T. 1994: Drug absorption from large intestine: physicochemical factors governing drug absorption. Biological and Pharmaceutical Bulletin 17(2): 327-333
Abrahamsson, B.; Alpsten, M.; Bake, B.; Jonsson, U.E.; Eriksson-Lepkowska, M.; Larsson, A. 1998: Drug absorption from nifedipine hydrophilic matrix extended-release (ER) tablet-comparison with an osmotic pump tablet and effect of food. Journal of Controlled Release: Official Journal of the Controlled Release Society 52(3): 301-310
Hunter, J.; Hirst, B.H.; Simmons, N.L. 1993: Drug absorption limited by P-glycoprotein-mediated secretory drug transport in human intestinal epithelial Caco-2 cell layers. Pharmaceutical Research 10(5): 743-749
Rouge, N.; Buri, P.; Doelker, E. 1996: Drug absorption sites in the gastrointestinal tract and dosage forms for site-specific delivery. International Journal Of Pharmaceutics (amsterdam). 136(1-2): 117-139
Augustijns, P.; Annaert, P.; Heylen, P.; Van-Den-Mooter, G.; Kinget, R. 1998: Drug absorption studies of prodrug esters using the Caco-2 model: Evaluation of ester hydrolysis and transepithelial transport. International Journal of Pharmaceutics (Amsterdam) 166(1): 45-53
Kuria, M.W. 1996: Drug abuse among urban as compared to rural secondary schools students in Kenya: a short communication. East African Medical Journal 73(5): 339
Canino, G.; Anthony, J.C.; Freeman, D.H.; Shrout, P.; Rubio-Stipec, M. 1993: Drug abuse and illicit drug use in Puerto Rico. American Journal of Public Health 83(2): 194-200
Kokkevi, A.; Stefanis, C. 1995: Drug abuse and psychiatric comorbidity. Comprehensive Psychiatry 36(5): 329-337
Brosseau, L.; Philippe, P.; Méthot, G.; Duquette, P.; Haraoui, B. 1993: Drug abuse as a risk factor of multiple sclerosis: case-control analysis and a study of heterogeneity. Neuroepidemiology 12(1): 6-14
Wernly, P.; Thormann, W. 1992: Drug of abuse confirmation in human urine using stepwise solid-phase extraction and micellar electrokinetic capillary chromatography. Analytical Chemistry 64(18): 2155-2159
Schulz-Schaeffer, W.; Peters, T.; Püschel, K. 1993: Drug abuse emergencies in Hamburg 1990/91. Forensic Science International 62(1-2): 167-171
Hawthorne, J.L.; Maier, R.C. 1993: Drug abuse in an obstetric population of a midsized city. Southern Medical Journal 86(12): 1334-1338
Christian, L.; Poling, A. 1997: Drug abuse in persons with mental retardation: a review. American Journal of Mental Retardation: Ajmr 102(2): 126-136
Silver, H.; Abboud, E. 1994: Drug abuse in schizophrenia: comparison of patients who began drug abuse before their first admission with those who began abusing drugs after their first admission. Schizophrenia Research 13(1): 57-63
Van Hasselt, V.B.; Hersen, M.; Null, J.A.; Ammerman, R.T.; Bukstein, O.G.; McGillivray, J.; Hunter, A. 1993: Drug abuse prevention for high-risk African American children and their families: A review and model program. Addictive Behaviors 18(2): 213-234
Varo-Galvan, P.; Carrera-Gonzalez, V.; Sevila-Salvador, F.; Sempere, C.-Guillem 1998: Drug abuse screening in urine. Quality control. Revista Espanola de Drogodependencias 23(1): 75-84
Colbert, D.L. 1994: Drug abuse screening with immunoassays: unexpected cross-reactivities and other pitfalls. British Journal of Biomedical Science 51(2): 136-146
Longshore, D.; Hsieh, S. 1998: Drug abuse treatment and risky sex: evidence for a cumulative treatment effect?. American Journal of Drug and Alcohol Abuse 24(3): 439-451
Siegal, H.A.; Carlson, R.G.; Falck, R.S.; Wang, J. 1995: Drug abuse treatment experience and HIV risk behaviors among active drug injectors in Ohio. American Journal of Public Health 85(1): 105-108
Simpson, D.D.; Joe, G.W.; Rowan Szal, G.A.; Greener, J.M. 1997: Drug abuse treatment process components that improve retention. Journal of Substance Abuse Treatment 14(6): 565-572,.-.
Simpson, D.D.; Joe, G.W.; Rowan-Szal, G.A. 1997: Drug abuse treatment retention and process effects on follow-up outcomes. Drug and Alcohol Dependence 47(3): 227-235
Kallan, J.E. 1998: Drug abuse--related mortality in the United States: patterns and correlates. American Journal of Drug and Alcohol Abuse 24(1): 103-117
Koob, G.F.; Le Moal, M. 1997: Drug abuse: Hedonic homeostatic dysregulation. Science 278(5335): 52-58
Hansen, S.S. 1997: Drug abusers in Danish mental hospitals. Addiction 92(4): 429-435
Jennerwein, M.; Andrews, P.A. 1994: Drug accumulation and DNA platination in cells exposed to aquated cisplatin species. Cancer Letters 81(2): 215-220
Knörle, R.; Schniz, E.; Feuerstein, T.J. 1998: Drug accumulation in melanin: An affinity chromatographic study. Journal of Chromatography. B, Biomedical Sciences and Applications 714(2): 171-179
Caravaca, F.; Soler, F.; Gomez-Fernandez, J.C.; Fernandez-Belda, F. 1995: Drug action of ritodrine on the sarcoplasmic reticulum Ca(2+)-ATPase from skeletal muscle. Archives of Biochemistry and Biophysics 318(1): 97-104
Cervar, M.; Nelson, D.M.; Kainer, F.; Desoye, G. 1997: Drug actions in preeclampsia: aspirin, but not magnesium chloride or dihydralazine, differentially inhibits cultured human trophoblast release of thromboxane and prostacyclin without affecting angiotensin II, endothelin-1, or leukotriene B4 secretion. American Journal of Obstetrics and Gynecology 176(1 Pt 1): 66-72
Golikov, P.P. 1994: Drug activation and inhibition of glucocorticoid receptors function as a basis for glucocorticoid effect regulation. Biokhimiya 59(5): 703-711
Steentoft, A.; Teige, B.; Holmgren, P.; Vuori, E.; Kristinsson, J.; Kaa, E.; Wethe, G.; Ceder, G.; Pikkarainen, J.; Simonsen, K.W. 1996: Drug addict deaths in the Nordic countries: A study based on medicolegally examined cases in the five Nordic countries in 1991. Forensic Science International 77(1-2): 109-118
Arvers, P.; Chirpaz, E.; Samson, E.; Pibarot, A.; Job, A.; Picard, J. 1997: Drug addiction among young male people: Sociocultural factors and background repercussions. Travaux Scientifiques des Chercheurs du Service de Sante des Armees 1997(18): 263-264
Koyal, S.N.; Marques, J.; Lee, E.Y.; Cooper, C.B.; Tashkin, D.P. 1998: Drug addiction and maximum exercise performance in humans: Cardio-pulmonary responses during maximum cycloergometry in habitual crack cocaine smokers and non cocaine users. Indian Journal of Physiology and Allied Sciences 52(2): 83-90
Lyvers, M. 1998: Drug addiction as a physical disease: the role of physical dependence and other chronic drug-induced neurophysiological changes in compulsive drug self-administration. Experimental and Clinical Psychopharmacology 6(1): 107-125
Ivanets, N.N.; Anokhina, I.P.; Strelets, N.V. 1997: Drug addiction in Russia. Zhurnal Nevrologii i Psikhiatrii Imeni S S Korsakova 97(9): 4-10
Noia, G.; de Santis, M.; Fundaro, C.; Mastromarino, C.; Trivellini, C.; Rosati, P.; Caruso, A.; Segni, G.; Mancuso, S. 1994: Drug addiction in pregnancy: 13 years of experience. Fetal Diagnosis and Therapy 9(2): 116-124
De Santis, M.; Noia, G.; di Lieto, M.P.; Fundaro, C.; Mastromarino, C.; Monni, M.; Trivellini, C.; Masini, L.; Caruso, A.; Mancuso, S. 1994: Drug addiction in pregnancy: the HIV infection. Fetal Diagnosis and Therapy 9(2): 125-129
Vaille, C. 1994: Drug addicts in the Netherlands. Annales Pharmaceutiques Francaises 52(6): 323-330
Roivas, L.; Neuvonen, P.J. 1994: Drug adsorption onto activated charcoal as a means of formulation. Methods and Findings in Experimental and Clinical Pharmacology 16(5): 367-372
Bleck, O.; Vielue, D. 1997: Drug allergy-nonsteroidal antiinflammatory drugs and analgesics. Allergologie 20(8): 375-384
Zhu, D.X.; Zhao, J.L.; Mo, L.; Li, H.L. 1997: Drug allergy: identification and characterization of IgE-reactivities to aspirin and related compounds. Journal of Investigational Allergology and Clinical Immunology 7(3): 160-168
Christophersen, A.S.; Mørland, J. 1994: Drug analysis for control purposes in forensic toxicology, workplace testing, sports medicine and related areas. Pharmacology and Toxicology 74(4-5): 202-210
Gross, G.A. 1994: Drug and alcohol abuse and cholesterol levels. Journal of the American Osteopathic Association 94(1): 55-6 61-2
Menezes, P.R.; Johnson, S.; Thornicroft, G.; Marshall, J.; Prosser, D.; Bebbington, P.; Kuipers, E. 1996: Drug and alcohol problems among individuals with severe mental illness in south London. British Journal of Psychiatry: the Journal of Mental Science 168(5): 612-619
McInnes, E.; Powell, J. 1994: Drug and alcohol referrals: are elderly substance abuse diagnoses and referrals being missed?. BMJ 308(6926): 444-446
Sjögren, H.; Björnstig, U.; Eriksson, A.; Ohman, U.; Solarz, A. 1997: Drug and alcohol use among injured motor vehicle drivers in Sweden: Prevalence, driver, crash, and injury characteristics. Alcoholism Clinical and Experimental Research 21(6): 968-973
Carvalho, V.; Pinsky, I.; De Souza e Silva, R.; Carlini-Cotrim, B. 1995: Drug and alcohol use and family characteristics: A study among Brazilian high-school students. Addiction 90(1): 65-72
Logan, B.K.; Schwilke, E.W. 1996: Drug and alcohol use in fatally injured drivers in Washington State. Journal of Forensic Sciences 41(3): 505-510
Jefferson, J.W. 1998: Drug and diet interactions: avoiding therapeutic paralysis. Journal of Clinical Psychiatry 59(Suppl 16): 31-39; Discussion: 40-42
Lewis, D.P.; Van Dyke, D.C.; Stumbo, P.J.; Berg, M.J. 1998: Drug and environmental factors associated with adverse pregnancy outcomes. Part I: Antiepileptic drugs, contraceptives, smoking, and folate. Annals of Pharmacotherapy 32(7-8): 802-817
Lewis, D.P.; Van Dyke, D.C.; Stumbo, P.J.; Berg, M.J. 1998: Drug and environmental factors associated with adverse pregnancy outcomes. Part II: Improvement with folic acid. Annals of PharmacoTherapy 32(9): 947-961
Kuitunen, T. 1994: Drug and ethanol effects on the clinical test for drunkenness: Single doses of ethanol, hypnotic drugs and antidepressant drugs. Pharmacology and Toxicology 75(2): 91-98
Fine, S.; Johnston, C. 1993: Drug and placebo side effects in methylphenidate-placebo trial for attention deficit hyperactivity disorder. Child Psychiatry and Human Development 24(1): 25-30
Marra, C.A.; Lynd, L.D.; McKerrow, R.; Carleton, B.C. 1996: Drug and poison information resources on the Internet, Part 1: An introduction. Pharmacotherapy 16(4): 537-546
Marra, C.A.; Carleton, B.C.; Lynd, L.D.; Marra, F.; McDougal, A.R.; Chow, D.; McKerrow, R. 1996: Drug and poison information resources on the Internet, Part 2: Identification and evaluation. Pharmacotherapy 16(5): 806-818
Tsai, J.C.; Weiner, N.; Flynn, G.L.; Ferry, J.J. 1994: Drug and vehicle deposition from topical applications: localization of minoxidil within skin strata of the hairless mouse. Skin Pharmacology: the Official Journal of the Skin Pharmacology Society 7(5): 262-269
Wooster, R.; Ebner, T.; Sutherland, L.; Clarke, D.; Burchell, B. 1993: Drug and xenobiotic glucuronidation catalysed by cloned human liver UDP-glucuronosyltransferases stably expressed in tissue culture cell lines. Toxicology 82(1-3): 119-129
Raza, H.; Montague, W. 1993: Drug and xenobiotic metabolising enzymes in camel liver: Multiple forms and species specific expression. Comparative Biochemistry and Physiology. C Comparative Pharmacology and Toxicology 104(1): 137-145
Ji, Y.; Zeng, G.Q.; Sun, D.X. 1994: Drug antagonism of TNF induced proliferation of bovine cerebromicrovascular smooth muscle cells. Yao Xue Xue Bao 29(2): 86-89
Pillans, P.I. 1996: Drug associated hepatic reactions in New Zealand: 21 years experience. New Zealand Medical Journal 109(1028): 315-319
Jenke, D.R. 1994: Drug binding by reservoirs in elastomeric infusion devices. Pharmaceutical Research 11(7): 984-989
Hervé, F.; Urien, S.; Albengres, E.; Duché, J.C.; Tillement, J.P. 1994: Drug binding in plasma. A summary of recent trends in the study of drug and hormone binding. Clinical Pharmacokinetics 26(1): 44-58
Okabe, N.; Hashizume, N. 1994: Drug binding properties of glycosylated human serum albumin as measured by fluorescence and circular dichroism. Biological and Pharmaceutical Bulletin 17(1): 16-21
Jetté, L.; Murphy, G.F.; Béliveau, R. 1998: Drug binding to P-glycoprotein is inhibited in normal tissues following SDZ-PSC 833 treatment. International Journal of Cancer 76(5): 729-737
Bhat, P.G.; Flanagan, D.R.; Donovan, M.D. 1996: Drug binding to gastric mucus glycoproteins. International Journal of Pharmaceutics (Amsterdam) 134(1-2): 15-25
Shida, T.; Ikeda, N.; Sekiguchi, J. 1996: Drug binding to higher ordered DNA structures: Ethidium bromide complexation with parallel quadruple-stranded DNA. Nucleosides and Nucleotides 15(1-3): 599-605
Hutt, A.J.; O'grady, J. 1996: Drug chirality: A consideration of the significance of the stereochemistry of antimicrobial agents. Journal of Antimicrobial ChemoTherapy 37(1): 7-32
Wechter, W.J. 1994: Drug chirality: on the mechanism of R-aryl propionic acid class NSAIDs. Epimerization in humans and the clinical implications for the use of racemates. Journal of Clinical Pharmacology 34(11): 1036-1042
Mnushko, Z.N.; Shevchenko, I.A. 1997: Drug choice for ethiotropic therapy of infectious disease. Farmatsiya 46(6): 8-10
Lovich, M.A.; Brown, L.; Edelman, E.R. 1997: Drug clearance and arterial uptake after local perivascular delivery to the rat carotid artery. Journal of the American College of Cardiology 29(7): 1645-1650
Vincent, H.H.; Vos, M.C.; Akçahuseyin, E.; Goessens, W.H.; van Duyl, W.A.; Schalekamp, M.A. 1993: Drug clearance by continuous haemodiafiltration. Analysis of sieving coefficients and mass transfer coefficients of diffusion. Blood Purification 11(2): 99-107
Antonelli, G.; Dianzani, F.; Bellarosa, D.; Turriziani, O.; Riva, E.; Gentile, A. 1994: Drug combination of AZT and ddI: synergism of action of prevention of appearance of AZT-resistance. Antiviral Chemistry and Chemotherapy 5(1): 51-55
Kaspers, G.J.; Veerman, A.J.; Pieters, R.; Van Zantwijk, I.; Hählen, K.; Van Wering, E.R. 1995: Drug combination testing in acute lymphoblastic leukemia using the MTT assay. Leukemia Research 19(3): 175-181
Zhu, Q.Y.; Scarborough, A.; Polsky, B.; Chou, T.C. 1996: Drug combinations and effect parameters of zidovudine, stavudine, and nevirapine in standardized drug-sensitive and resistant HIV type 1 strains. Aids Research and Human Retroviruses 12(6): 507-517
Lichter, I.; Hunt, E. 1995: Drug combinations in syringe drivers. New Zealand Medical Journal 108(1001): 224-226
Grassby, P.F.; Hutchings, L. 1997: Drug combinations in syringe drivers: the compatibility and stability of diamorphine with cyclizine and haloperidol. Palliative Medicine 11(3): 217-224
Eva, F.; Tibor, K. 1997: Drug combinations in the control of dog and cat helminthoses: Review. Magyar Allatorvosok Lapja 119(6): 345-347
Barlow, J.W.; Curtis, A.J.; Raggatt, L.E.; Loidl, N.M.; Topliss, D.J.; Stockigt, J.R. 1994: Drug competition for intracellular triiodothyronine-binding sites. European Journal of Endocrinology 130(4): 417-421
Lee, M.R. 1993: Drug compliance. Proceedings of the Royal Society of Edinburgh Section B (Biological Sciences) 101: 227-239
Khalil, S.A.; Elzubier, A.G. 1997: Drug compliance among hypertensive patients in Tabuk, Saudi Arabia. Journal of Hypertension 15(5): 561-565
Boudes, P. 1998: Drug compliance in therapeutic trials: A review. Controlled Clinical Trials 19(3): 257-268
Iwai, N. 1997: Drug compliance of children and infants with oral antibiotics for pediatric use. Acta Paediatrica Japonica: Overseas Edition 39(1): 132-142
Kepler, T.B.; Perelson, A.S. 1998: Drug concentration heterogeneity facilitates the evolution of drug resistance. Proceedings of the National Academy of Sciences of the United States of America 95(20): 11514-11519
Fuller, R.W.; Snoddy, H.D. 1993: Drug concentrations in mouse brain at pharmacologically active doses of fluoxetine enantiomers. Biochemical Pharmacology 45(11): 2355-2358
Mikamo, H.; Izumi, K.; Ito, K.; Yamada, Y.; Tamaya, T. 1992: Drug concentrations in the pelvic retroperitoneal space exudate after the combined administration of cephems and amikacin. Drug Investigation 4(6): 459-465
Mikamo, H.; Kawazoe, K.; Izumi, K.; Ito, K.; Yamada, Y.; Tamaya, T. 1994: Drug concentrations in the pelvic retroperitoneal space exudate after the combined administration of cephems and astromicin. Current Therapeutic Research 55(6): 632-640
Pinheiro Carrera, M.; Brunhara, F.C.; Schwarting, R.K.; Tomaz, C. 1998: Drug conditioning induced by intrastriatal apomorphine administration. Brain Research 790(1-2): 60-66
Asakura, T.; Takahashi, N.; Takada, K.; Inoue, T.; Ohkawa, K. 1997: Drug conjugate of doxorubicin with glutathione is a potent reverser of multidrug resistance in rat hepatoma cells. Anti-Cancer Drugs 8(2): 199-203
Leininger-Muller, B.; Siest, G.; Minn, A. 1994: Drug conjugation in the brain. Therapie 49(6): 499-507
Verez Vivero, L.; Fernandez Merino, M.D.l Carmen; Gude Sampedro, F.; Tato Campos, A.; Rey Garcia, J.; Beceiro Diaz, F. 1997: Drug consumption by the elderly and its relation with socioeconomic variables and self-perception of health. Revista Espanola de Geriatria y Gerontologia 32(3): 151-155
Pahor, M.; Chrischilles, E.A.; Guralnik, J.M.; Brown, S.L.; Wallace, R.B.; Carbonin, P. 1994: Drug data coding and analysis in epidemiologic studies. European Journal of Epidemiology 10(4): 405-411
Penning, R.; Fromm, E.; Betz, P.; Kauert, G.; Drasch, G.; von Meyer, L. 1993: Drug death autopsies at the Munich Institute of Forensic Medicine (1981-1992). Forensic Science International 62(1-2): 135-139
Friedrich, L.V.; White, R.L.; Kays, M.B.; Burgess, D.S. 1994: Drug degradation during HPLC analysis of aztreonam: effect on pharmacokinetic parameter estimation. Annals of PharmacoTherapy 28(4): 444-446
Murray, N.; Coppin, C.; Coldman, A.; Pater, J.; Rapp, E. 1994: Drug delivery analysis of the Canadian multicenter trial in non-small-cell lung cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 12(11): 2333-2339
Langer, R. 1998: Drug delivery and targeting. Nature 392(6679 Suppl): 5-10
Meakin, B.J.; Cainey, J.M.; Woodcock, P.M. 1995: Drug delivery characteristics of bricanyl turbohaler dry powder inhalers. International Journal of Pharmaceutics (Amsterdam) 119(1): 91-102
Schierholz, J.M.; Rump, A.; Pulverer, G. 1996: Drug delivery concepts for the efficacious prevention of foreign-body infections. Zentralblatt für Bakteriologie: International Journal of Medical Microbiology 284(2-3): 390-401
Carr, M.G.; Corish, J.; Corrigan, O.I. 1997: Drug delivery from a liquid crystalline base across Visking and human stratum corneum. International Journal Of Pharmaceutics (amsterdam). 157(1): 35-42,. 14
Gibson, P.G.; Wlodarczyk, J.H.; Borgas, T. 1995: Drug delivery in asthma: A comparison of spacers with a jet nebuliser. Australian and New Zealand Journal of Medicine 25(4): 324-329
Stratton, L.P.; Dong, A.; Manning, M.C.; Carpenter, J.F. 1997: Drug delivery matrix containing native protein precipitates suspended in a poloxamer gel. Journal of Pharmaceutical Sciences 86(9): 1006-1010
Bellazzi, R. 1993: Drug delivery optimization through Bayesian networks: An application to erythropoietin therapy in uremic anemia. Computers and Biomedical Research An International Journal 26(3): 274-293
Hovgaard, L.; Brøndsted, H.; Buur, A.; Bundgaard, H. 1995: Drug delivery studies in Caco-2 monolayers. Synthesis, hydrolysis, and transport of O-cyclopropane carboxylic acid ester prodrugs of various beta-blocking agents. Pharmaceutical Research 12(3): 387-392
Hovgaard, L.; Brondsted, H.; Nielsen, H.-Morck 1995: Drug delivery studies in Caco-2 monolayers: II. Absorption enhancer effects of lysophosphatidylcholines. International Journal of Pharmaceutics (Amsterdam) 114(2): 141-149
Brondsted, H.; Nielsen, H.-Morck; Hovgaard, L. 1995: Drug delivery studies in Caco-2 monolayers: III. Intestinal transport of various vasopressin analogues in the presence of lysophosphatidylcholine. International Journal of Pharmaceutics (Amsterdam) 114(2): 151-157
Hovgaard, L.; Brøndsted, H. 1995: Drug delivery studies in Caco-2 monolayers. IV. Absorption enhancer effects of cyclodextrins. Pharmaceutical Research 12(9): 1328-1332
Banerjee, G.; Nandi, G.; Mahato, S.B.; Pakrashi, A.; Basu, M.K. 1996: Drug delivery system: Targeting of pentamidines to specific sites using sugar grafted liposomes. Journal of Antimicrobial ChemoTherapy 38(1): 145-150
Uglea, C.V.; Albu, I.; Vătăjanu, A.; Croitoru, M.; Antoniu, S.; Panaitescu, L.; Ottenbrite, R.M. 1994: Drug delivery systems based on inorganic materials: I. Synthesis and characterization of a zeolite-cyclophosphamide system. Journal of Biomaterials Science. Polymer Edition 6(7): 633-637
Greenwald, R.B.; Gilbert, C.W.; Pendri, A.; Conover, C.D.; Xia, J.; Martinez, A. 1996: Drug delivery systems: water soluble taxol 2'-poly(ethylene glycol) ester prodrugs-design and in vivo effectiveness. Journal of Medicinal Chemistry 39(2): 424-431
Walker, W.L.; Cook, J. 1996: Drug delivery to brain tumors. Bulletin of Mathematical Biology 58(6): 1047-1074
Kakinuma, K.; Tanaka, R.; Takahashi, H.; Sekihara, Y.; Watanabe, M.; Kuroki, M. 1996: Drug delivery to the brain using thermosensitive liposome and local hyperthermia. International Journal of Hyperthermia: the Official Journal of European Society for Hyperthermic Oncology North American Hyperthermia Group 12(1): 157-165
Terasaki, T.; Tsuji, A. 1994: Drug delivery to the brain utilizing blood-brain barrier transport systems. Journal of Controlled Release 29(1-2): 163-169
Ishikura, T.; Senou, T.; Ishihara, H.; Kato, T.; Ito, T. 1995: Drug delivery to the brain. DOPA prodrugs based on a ring-closure reaction to quaternary thiazolium compounds. International Journal of Pharmaceutics (Amsterdam) 116(1): 51-63
Kok, R.J.; Haas, M.; Moolenaar, F.; de Zeeuw, D.; Meijer, D.K. 1998: Drug delivery to the kidneys and the bladder with the low molecular weight protein lysozyme. Renal Failure 20(2): 211-217
Maysinger, D.; Morinville, A. 1997: Drug delivery to the nervous system. Trends in Biotechnology 15(10): 410-418
Timsina, M.P.; Martin, G.P.; Marriott, C.; Ganderton, D.; Yianneskis, M. 1994: Drug delivery to the respiratory tract using dry powder inhalers. International Journal Of Pharmaceutics (amsterdam). 101(1-2): 1-13
Thompson, P.J. 1998: Drug delivery to the small airways. American Journal of Respiratory and Critical Care Medicine 157(5 Part 2): S199-S202
Walker, I.; Nicholls, D.; Irwin, W., J.; Freeman, S. 1994: Drug delivery via active transport at the blood-brain barrier: Affinity of a prodrug of phosphonoformate for the large amino acid transporter. International Journal of Pharmaceutics (Amsterdam) 104(2): 157-167
Walker, I.; Nicholls, D.; Irwin, W., J.; Freeman, S. 1994: Drug delivery via active transport at the blood-brain barrier: II. Investigation of monocarboxylic acid transport in vitro. International Journal of Pharmaceutics (Amsterdam) 108(3): 225-232
Guedeau-Boudeville, M.A.; Jullien, L.; di Meglio, J.M. 1995: Drug delivery: piercing vesicles by their adsorption onto a porous medium. Proceedings of the National Academy of Sciences of the United States of America 92(21): 9590-9592
Svikis, D.; McCaul, M.; Feng, T.; Stuart, M.; Fox, M.; Stokes, E. 1998: Drug dependence during pregnancy. Effect of an on-site support group. Journal of Reproductive Medicine 43(9): 799-805
Fujikawa, K.; Akiyama, Y.; Takayama, S. 1994: Drug dependence study of the new cognition-enhancing agent nefiracetam in rats. Arzneimittel-Forschung 44(2a): 243-247
Takada, K.; Yanagita, T. 1997: Drug dependence study on vigabatrin in rhesus monkeys and rats. Arzneimittel-Forschung 47(10): 1087-1092
Varghese, J.N.; Smith, P.W.; Sollis, S.L.; Blick, T.J.; Sahasrabudhe, A.; McKimm-Breschkin, J.L.; Colman, P.M. 1998: Drug design against a shifting target: A structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase. Structure 6(6): 735-746
King, R.D.; Muggleton, S.; Lewis, R.A.; Sternberg, M.J. 1992: Drug design by machine learning: the use of inductive logic programming to model the structure-activity relationships of trimethoprim analogues binding to dihydrofolate reductase. Proceedings of the National Academy of Sciences of the United States of America 89(23): 11322-11326
Hendry, L.B. 1993: Drug design with a new type of molecular modeling based on stereochemical complementarity to gene structure. Journal of Clinical Pharmacology 33(12): 1173-1187
Blanc, P.D.; Saxena, M.; Olson, K.R. 1994: Drug detection and trauma cause--a case control study of fatal injuries. Journal of Toxicology. Clinical Toxicology 32(2): 137-145
Moeller, M.R. 1992: Drug detection in hair by chromatographic procedures. Journal of Chromatography 580(1-2): 125-134
Freeman, H.L. 1994: Drug development report (11): Clinical issues in the use of risperidone. Journal of Drug Development 6(4): 153-157
Mustafa, T.; Srivastava, K.C.; Jensen, K.B. 1993: Drug development report: 9. Pharmacology of ginger, Zingiber officinale. Journal of Drug Development 6(1): 25-39
Peppas, N.A.; Wright, S.L. 1998: Drug diffusion and binding in ionizable interpenetrating networks from poly(vinyl alcohol) and poly(acrylic acid). European Journal of Pharmaceutics and Biopharmaceutics: Official Journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik E.V 46(1): 15-29
Rao, P.R.; Diwan, P.V. 1996: Drug diffusion from cellulose acetate-polyvinyl pyrrolidone free films for transdermal administration. Indian Journal of Pharmaceutical Sciences 58(6): 246-250
Colombo, P.; Bettini, R.; Massimo, G.; Catellani, P.L.; Santi, P.; Peppas, N.A. 1995: Drug diffusion front movement is important in drug release control from swellable matrix tablets. Journal of Pharmaceutical Sciences 84(8): 991-997
Bhat, P.G.; Flanagan, D.R.; Donovan, M.D. 1996: Drug diffusion through cystic fibrotic mucus: steady-state permeation, rheologic properties, and glycoprotein morphology. Journal of Pharmaceutical Sciences 85(6): 624-630
Fitzgerald, J.D. 1998: Drug discovery and strategic marketing: The need to improve the connection. Drug Development Research 43(3): 143-148
Whitley, R.J. 1996: Drug discovery for human immunodeficiency virus infection: conquests and hurdles. Journal of Antimicrobial ChemoTherapy 37(Suppl): 151-159
Lamb, P.; Rosen, J. 1997: Drug discovery using receptors that modulate gene expression. Journal of Receptor and Signal Transduction Research 17(1-3): 531-543
Ator, N.A.; Grant, K.A.; Purdy, R.H.; Paul, S.M.; Griffiths, R.R. 1993: Drug discrimination analysis of endogenous neuroactive steroids in rats. European Journal of Pharmacology 241(2-3): 237-243
Balster, R.L.; Grech, D.M.; Bobelis, D.J. 1992: Drug discrimination analysis of ethanol as an N-methyl-D-aspartate receptor antagonist. European Journal of Pharmacology 222(1): 39-42
Sannerud, C.A.; Ator, N.A. 1995: Drug discrimination analysis of midazolam under a three-lever procedure. II: Differential effects of benzodiazepine receptor agonists. Journal of Pharmacology and Experimental Therapeutics 275(1): 183-193
Sannerud, C.A.; Ator, N.A. 1995: Drug discrimination analysis of midazolam under a three-lever procedure: I. Dose-dependent differences in generalization and antagonism. Journal of Pharmacology and Experimental Therapeutics 272(1): 100-111
Tongjaroenbuangam, W.; Meksuriyen, D.; Govitrapong, P.; Kotchabhakdi, N.; Baldwin, B.A. 1998: Drug discrimination analysis of pseudoephedrine in rats. Pharmacology Biochemistry and Behavior 59(2): 505-510
Huang, X.; Marona-Lewicka, D.; Pfaff, R.C.; Nichols, D.E. 1994: Drug discrimination and receptor binding studies of N-isopropyl lysergamide derivatives. Pharmacology Biochemistry and Behavior 47(3): 667-673
Picker, M.J. 1998: Drug discrimination history: pigeons trained to discriminate opioids with activity at different receptor types. Experimental and Clinical Psychopharmacology 6(2): 139-148
Tidey, J.W.; Bergman, J. 1998: Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs. Journal of Pharmacology and Experimental Therapeutics 285(3): 1163-1174
Barrett, R.J.; Caul, W.F.; Huffman, E.M.; Smith, R.L. 1994: Drug discrimination is a continuous rather than a quantal process following training on a VI-TO schedule of reinforcement. Psychopharmacology 113(3-4): 289-96; discussion 297-303
Marston, H.M.; Garcha, H.S.; Robbins, T.W.; Stolerman, I.P. 1992: Drug discrimination learning in rats with excitotoxic lesions of nucleus basalis and ventral globus pallidus. Behavioural Brain Research 51(1): 93-102
Skinner, D., M.; Martin, G., M.; Howe, R., D.; Pridgar, A.; Van-Der-Kooy, D. 1995: Drug discrimination learning using a taste aversion paradigm: An assessment of the role of safety cues. Learning and Motivation 26(4): 343-369
Mariathasan, E.A.; Stolerman, I.P. 1992: Drug discrimination studies in rats with caffeine and phenylpropanolamine administered separately and as mixtures. Psychopharmacology 109(1-2): 99-106
Marona-Lewicka, D.; Nichols, D.E. 1998: Drug discrimination studies of the interoceptive cues produced by selective serotonin uptake inhibitors and selective serotonin releasing agents. Psychopharmacology 138(1): 67-75
McMillan, D.E.; Li, M.; Hardwick, W.C. 1997: Drug discrimination under a concurrent fixed-interval fixed-interval schedule. Journal of the Experimental Analysis of Behavior 68(2): 193-217
Snodgrass, S.H.; McMillan, D.E. 1996: Drug discrimination under a concurrent schedule. Journal of the Experimental Analysis of Behavior 65(3): 495-512
Parker, B.K.; Schaal, D.W.; Miller, M. 1994: Drug discrimination using a Pavlovian conditional discrimination paradigm in pigeons. Pharmacology Biochemistry and Behavior 49(4): 955-960
Morgan, D.J. 1997: Drug disposition in mother and foetus. Clinical and Experimental Pharmacology and Physiology 24(11): 869-873
Gal, P.; Gilman, J.T. 1993: Drug disposition in neonates with patent ductus arteriosus. Annals of Pharmacotherapy 27(11): 1383-1388
Usui, T.; Tanaka, S.; Sonoda, T.; Ozawa, Y.; Teramura, K.; Nakamura, E.; Watanabe, T.; Higuchi, S. 1997: Drug disposition of incadronate, a new bisphosphonate, in rats with bone metastases. Xenobiotica; the Fate of Foreign Compounds in Biological Systems 27(5): 479-487
Xia, S.; Liu, L.; Feng, C.; Guo, A. 1997: Drug disruption of short-term memory in Drosophila melanogaster. Pharmacology Biochemistry and Behavior 58(3): 727-735
Ishizaka, T.; Honda, H.; Koishi, M. 1993: Drug dissolution from indomethacin-starch hybrid powders prepared by the dry impact blending method. Journal of Pharmacy and Pharmacology 45(9): 770-774
Uchegbu, I.F.; Turton, J.A.; Double, J.A.; Florence, A.T. 1994: Drug distribution and a pulmonary adverse effect of intraperitoneally administered doxorubicin niosomes in the mouse. Biopharmaceutics and Drug Disposition 15(8): 691-707
Tsuneizumi, T.; Babb, S.M.; Cohen, B.M. 1992: Drug distribution between blood and brain as a determinant of antipsychotic drug effects. Biological Psychiatry 32(9): 817-824
Kalasinsky, K.S. 1998: Drug distribution in human hair by infrared microscopy. Cellular and Molecular Biology 44(1): 81-87
Offidani, C.; Strano Rossi, S.; Chiarotti, M. 1993: Drug distribution in the head, axillary and pubic hair of chronic addicts. Forensic Science International 63(1-3): 105-108
Mac-Kay, M.V.; Sanchez Burson, J.; Martinez-Lanao, J.; Dominguez-Gil, A. 1993: Drug dosage in end-stage renal disease (ESRD) patients undergoing haemodialysis. A predictive study based on a microcomputer program. Clinical Pharmacokinetics 25(3): 243-257
Talbert, R.L. 1994: Drug dosing in renal insufficiency. Journal of Clinical Pharmacology 34(2): 99-110
Brown, S.A. 1993: Drug effect expectancies and addictive behavior change. Experimental and Clinical Psychopharmacology 1(1-4): 55-67
Beuzen, A.; Belzung, C.; Roullet, P. 1994: Drug effects in a radial maze designed for dissociation of cues used by mice. Pharmacology Biochemistry and Behavior 48(1): 23-29
Donovan, M.D.; Zhou, M. 1995: Drug effects on in vivo nasal clearance in rats. International Journal Of Pharmaceutics (amsterdam). 116(1): 77-86
Wiese, M.; Seydel, U. 1996: Drug effects on intracellular mycobacteria determined by mass spectrometric analysis of the Na(+)-to-K+ ratios of individual bacterial organisms. Antimicrobial Agents and ChemoTherapy 40(9): 2047-2053
Millar, J.C.; Wilson, W.S.; Carr, R.D.; Humphries, R.G. 1995: Drug effects on intraocular pressure and vascular flow in the bovine perfused eye using radiolabelled microspheres. Journal of Ocular Pharmacology and Therapeutics: the Official Journal of the Association for Ocular Pharmacology and Therapeutics 11(1): 11-23
Hudzik, T.J.; McMillan, D.E. 1994: Drug effects on response duration differentiation. I: Differential effects of drugs of abuse. Psychopharmacology 114(4): 620-627
Hudzik, T.J.; McMillan, D.E. 1994: Drug effects on response-duration differentiation. II: Selective effects of antidepressant drugs. Journal of Pharmacology and Experimental Therapeutics 268(3): 1335-1342
Hudzik, T.J.; McMillan, D.E. 1995: Drug effects on response-duration differentiation. IV: Effects of trimethyltin. Neurotoxicology and Teratology 17(6): 665-671
Metelitsa, L.A.; Mogilevich, S.E.; Luik, A.I. 1996: Drug effects on the results of passive hemagglutination test. Klinicheskaya Laboratornaya Diagnostika 1996(2): 46-47
Lim, C.F.; Loidl, N.M.; Kennedy, J.A.; Topliss, D.J.; Stockigt, J.R. 1996: Drug effects on triiodothyronine uptake by rat anterior pituitary cells in vitro. Experimental and Clinical Endocrinology and Diabetes: Official Journal German Society of Endocrinology and German Diabetes Association 104(2): 151-157
Costa, T.; Ogino, Y.; Munson, P.J.; Onaran, H.O.; Rodbard, D. 1992: Drug efficacy at guanine nucleotide-binding regulatory protein-linked receptors: thermodynamic interpretation of negative antagonism and of receptor activity in the absence of ligand. Molecular Pharmacology 41(3): 549-560
Williams, J.B. 1996: Drug efflux as a mechanism of resistance. British Journal of Biomedical Science 53(4): 290-293
Sardini, A.; Mintenig, G.M.; Valverde, M.A.; Sepúlveda, F.V.; Gill, D.R.; Hyde, S.C.; Higgins, C.F.; McNaughton, P.A. 1994: Drug efflux mediated by the human multidrug resistance P-glycoprotein is inhibited by cell swelling. Journal of Cell Science 107: 3281-3290
van Veen, H.W.; Konings, W.N. 1997: Drug efflux proteins in multidrug resistant bacteria. Biological Chemistry 378(8): 769-777
Lang, P.; Zenker, C. 1993: Drug emergencies in Bremen in 1991 and 1992. Forensic Science International 62(1-2): 111-116
Zenker, C.; Lang, P. 1993: Drug emergency patients are a burden for the medical care system: Inadequate care for drug emergency patients. Forensic Science International 62(1-2): 117-120
Hammarlund-Udenaes, M.; Paalzow, L.K.; de Lange, E.C. 1997: Drug equilibration across the blood-brain barrier--pharmacokinetic considerations based on the microdialysis method. Pharmaceutical Research 14(2): 128-134
Miyoshi, H.; Kanzaki, T. 1998: Drug eruption (erythema multiforme type) due to a digestive enzyme drug. Journal of Dermatology 25(1): 28-31
Kawana, S. 1997: Drug eruption induced by cyanamide (carbimide): a clinical and histopathologic study of 7 patients. Dermatology 195(1): 30-34
Dykewicz, M.S.; McMorrow, N.K.; Davison, R.; Fintel, D.J.; Zull, C.C.; Rutledge, J.L. 1995: Drug eruptions and isotypic antibody responses to streptokinase after infusions of anisoylated plasminogen-streptokinase complex (APSAC, anistreplase). Journal of Allergy and Clinical Immunology 95(5 Pt 1): 1020-1028
Higashi, N.; Matsumura, T.; Isonokami, M.; Iwasa, M.; Komamura, H. 1993: Drug eruptions: Clinical and diagnostic aspects of 93 patients at the Department of Dermatology, Sakai Municipal Hospital (1985-1989). Skin Research 35(2): 235-246
Brun-Pascaud, M.; Rajagopalan-Levasseur, P.; Chau, F.; Bertrand, G.; Garry, L.; Derouin, F.; Girard, P.M. 1998: Drug evaluation of concurrent Pneumocystis carinii, Toxoplasma gondii, and Mycobacterium avium complex infections in a rat model. Antimicrobial Agents and ChemoTherapy 42(5): 1068-1072
Denig, P.; Haaijer-Ruskamp, F.M.; Wesseling, H.; Versluis, A. 1993: Drug expectations and drug choices of hospital physicians. Journal of Internal Medicine 234(2): 155-163
Evers, R.; Kool, M.; van Deemter, L.; Janssen, H.; Calafat, J.; Oomen, L.C.; Paulusma, C.C.; Oude Elferink, R.P.; Baas, F.; Schinkel, A.H.; Borst, P. 1998: Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA. Journal of Clinical Investigation 101(7): 1310-1319
Sagatun-Edwards, I.J.; Saylor, C.; Shifflett, B. 1995: Drug exposed infants in the social welfare system and juvenile court. Child Abuse and Neglect 19(1): 83-91
McMahon, A.D.; Evans, J.M.; McGilchrist, M.M.; McDevitt, D.G.; MacDonald, T.M. 1998: Drug exposure risk windows and unexposed comparator groups for cohort studies in pharmacoepidemiology. Pharmacoepidemiology and Drug Safety 7(4): 275-280
Arimori, K.; Nakano, M. 1998: Drug exsorption from blood into the gastrointestinal tract. Pharmaceutical Research 15(3): 371-376
Kaidoh, K.; Kimura, M.; Miyauchi, S.; Nara, T.; Kamo, N. 1997: Drug extrusion in Corynebacterium glutamicum. Microbial Drug Resistance 3(4): 345-350
Elsea, S.H.; McGuirk, P.R.; Gootz, T.D.; Moynihan, M.; Osheroff, N. 1993: Drug features that contribute to the activity of quinolones against mammalian topoisomerase II and cultured cells: correlation between enhancement of enzyme-mediated DNA cleavage in vitro and cytotoxic potential. Antimicrobial Agents and ChemoTherapy 37(10): 2179-2186
Sabeel, A.; Al Meshari, K.; Abutaleb, N.; Al Shaibani, K. 1998: Drug fever induced by azathioprine in a haemodialysis patient. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 13(4): 1004-1005
Tzou, T.Z.; Pachuta, R.R.; Coy, R.B.; Schultz, R.K. 1997: Drug form selection in albuterol-containing metered-dose inhaler formulations and its impact on chemical and physical stability. Journal of Pharmaceutical Sciences 86(12): 1352-1357
Mcgurk, K.A.; Brierley, C.H.; Burchell, B. 1998: Drug glucuronidation by human renal UDP-glucuronosyltransferases. Biochemical Pharmacology 55(7): 1005-1012
Lilley, K.A.; Wheat, T.E. 1996: Drug identification in biological matrices using capillary electrophoresis and chemometric software. Journal of Chromatography. B, Biomedical Applications 683(1): 67-76
Katagiri, K.; Takayasu, S. 1996: Drug induced acute generalized exanthematous pustulosis. Journal of Dermatology 23(9): 623-627
Lankisch, P.G.; Dröge, M.; Gottesleben, F. 1995: Drug induced acute pancreatitis: incidence and severity. Gut 37(4): 565-567
Satani, Y.; Uede, K.; Matsunaka, M. 1995: Drug induced and aggravated pustular psoriasis. Skin Research 37(2): 261-267
Beaugerie, L.; Luboinski, J.; Brousse, N.; Cosnes, J.; Chatelet, F.P.; Gendre, J.P.; Le Quintrec, Y. 1994: Drug induced lymphocytic colitis. Gut 35(3): 426-428
Wareing, M.; Mitchell, D. 1996: Drug induced otalgia due to mesalazine and sulphasalazine. Journal of Laryngology and Otology 110(5): 466-467
Joshi, M.P. 1998: Drug information service at teaching hospitals in developing countries. Indian Journal of Pharmacology 30(1): 1-5
Mayumi, H.; Kawachi, Y.; Kohno, H.; Akaiwa, Y.; Hisahara, M.; Fukae, K.; Nakashima, A.; Yasui, H. 1994: Drug infusion through a branch of the aortocoronary vein graft for refractory coronary spasm. Annals of Thoracic Surgery 58(3): 869-871
Poshyachinda, V. 1993: Drug injecting and HIV infection among the population of drug abusers in Asia. Bulletin on Narcotics 45(1): 77-90
Gore, S.M.; Bird, A.G.; Burns, S.M.; Goldberg, D.J.; Ross, A.J.; Macgregor, J. 1995: Drug injection and HIV prevalence in inmates of Glenochil prison. BMJ 310(6975): 293-296
Maggi, P.; Fullone, M.; Federico, M.; Angarano, G.; Pastore, G.; Regina, G. 1995: Drug injection in jugular veins: a new risk factor for vascular diseases in HIV-infected patients? A case report. Angiology 46(11): 1049-1052
Capone, D.; Aiello, C.; Santoro, G.A.; Gentile, A.; Stanziale, P.; D'Alessandro, R.; Imperatore, P.; Basile, V. 1996: Drug interaction between cyclosporine and two antimicrobial agents, josamycin and rifampicin, in organ-transplanted patients. International Journal of Clinical Pharmacology Research 16(2-3): 73-76
Nakai, A.; Nishikata, M.; Matsuyama, K.; Ichikawa, M. 1996: Drug interaction between simvastatin and cholestyramine in vitro and in vivo. Biological and Pharmaceutical Bulletin 19(9): 1231-1233
Ishikawa, M.; Takayanagi, Y.; Sasaki, K. 1993: Drug interaction effects on antitumor drugs. XIII. Amelioration of cisplatin lethality and renal toxicity by chlorpromazine in mice. Biological and Pharmaceutical Bulletin 16(11): 1104-1107
Ishikawa, M.; Aoki, T.; Yomogida, S.; Takayanagi, Y.; Sasaki, K. 1994: Drug interaction effects on antitumour drugs (XV): Disulfiram as protective agent against cyclophosphamide-induced urotoxicity without compromising antitumour activity in mice. Pharmacology and Toxicology 74(4-5): 255-261
Harstrick, A.; Vanhoefer, U.; Heidemann, A.; Druyen, H.; Wilke, H.; Seeber, S. 1997: Drug interactions of 5-fluorouracil with either cisplatin or lobaplatin--a new, clinically active platinum analog in established human cancer cell lines. Anti-Cancer Drugs 8(4): 391-395
Krishnaiah, Y.S.R.; Satyanarayana, S.; Visweswaram, D. 1993: Drug interaction of tolbutamide with ketoconazole in diabetic rabbits. Indian Journal of Pharmacology 25(3): 146-148
Van Cleef, G.F.; Fisher, E.J.; Polk, R.E. 1997: Drug interaction potential with inhibitors of HIV protease. Pharmacotherapy 17(4): 774-778
Bourgeois, B.F. 1996: Drug interaction profile of topiramate. Epilepsia 37(Suppl): S14-S17
Daniels, S.; Schentag, J.J. 1993: Drug interaction studies and safety of famciclovir in healthy volunteers: A review. Antiviral Chemistry and Chemotherapy 4(Suppl 1): 57-64
Kuhlmann, J. 1994: Drug interaction studies during drug development: which, when, how?. International Journal of Clinical Pharmacology and Therapeutics 32(6): 305-311
Surekha, V.; Peter, J.V.; Jeyaseelan, L.; Cherian, A.M. 1997: Drug interaction: rifampicin and glibenclamide. National Medical Journal of India 10(1): 11-12
DeVane, C.L. 1996: Drug interactions and antipsychotic therapy. PharmacoTherapy 16(1 Pt 2): 15-20
Lampen, A.; Christians, U.; Bader, A.; Hackbarth, I.; Sewing, K.F. 1996: Drug interactions and interindividual variability of ciclosporin metabolism in the small intestine. Pharmacology 52(3): 159-168
Pauwels, O. 1997: Drug interactions and tacrolimus (FK506). Journal de Pharmacie Clinique 16(2): 75-81
Dawson, J.; Karalliedde, L. 1998: Drug interactions and the clinical anaesthetist. European Journal of Anaesthesiology 15(2): 172-189
Chan, T.Y. 1998: Drug interactions as a cause of overanticoagulation and bleedings in Chinese patients receiving warfarin. International Journal of Clinical Pharmacology and Therapeutics 36(7): 403-405
Nagai, N.; Furuhata, M.; Ogata, H. 1995: Drug interactions between theophylline and H2-antagonists, roxatidine acetate hydrochloride and cimetidine: pharmacokinetic analysis in rats in vivo. Biological and Pharmaceutical Bulletin 18(11): 1610-1613
Virani, A.; Mailis, A.; Shapiro, L.E.; Shear, N.H. 1997: Drug interactions in human neuropathic pain pharmacotherapy. Pain 73(1): 3-13
Zimmerman, J. 1992: Drug interactions in intestinal transport of folic acid and methotrexate. Further evidence for the heterogeneity of folate transport in the human small intestine. Biochemical Pharmacology 44(9): 1839-1842
Seifeldin, R. 1995: Drug interactions in transplantation. Clinical Therapeutics 17(6): 1043-1061
Bachmann, K.A.; Sullivan, T.J.; Jauregui, L.; Reese, J.; Miller, K.; Levine, L. 1994: Drug interactions of H2-receptor antagonists. Scandinavian Journal of Gastroenterology. Supplement 206: 14-19
Watkins, V.S.; Polk, R.E.; Stotka, J.L. 1997: Drug interactions of macrolides: emphasis on dirithromycin. Annals of PharmacoTherapy 31(3): 349-356
Tasaki, K.; Minami, T.; Ieiri, I.; Ohtsubo, K.; Hirakawa, Y.; Ueda, K.; Higuchi, S. 1995: Drug interactions of zonisamide with phenytoin and sodium valproate: Serum concentrations and protein binding. Brain and Development 17(3): 182-185
Nahata, M. 1996: Drug interactions with azithromycin and the macrolides: An overview. Journal of Antimicrobial ChemoTherapy 37(Suppl): 133-142
Quist Christensen, L.; Bonde, J.; Kampmann, J.P. 1994: Drug interactions with intravenous and local anaesthetics. Acta Anaesthesiologica Scandinavica 38(1): 15-29
Greenblatt, D.J.; von Moltke, L.L.; Harmatz, J.S.; Shader, R.I. 1998: Drug interactions with newer antidepressants: role of human cytochromes P450. Journal of Clinical Psychiatry 59(Suppl): 19-27
Callingham, B.A. 1993: Drug interactions with reversible monoamine oxidase-A inhibitors. Clinical Neuropharmacology 16(Suppl): S42-S50
Baker, S.D. 1997: Drug interactions with the taxanes. PharmacoTherapy 17(5 Pt 2): 126s-132s
de Boer, A.; van Griensven, J.M. 1995: Drug interactions with thrombolytic agents. Current perspectives. Clinical Pharmacokinetics 28(4): 315-326
Di-Castri, A.; Jacquot, J.M.; Hemmi, P.; Moati, L.; Rouy, J.M.; Compan, B.; Nachar, H.; Bossy-Vassal, A. 1995: Drug interactions: A study of 409 prescriptions at discharge from geriatric hospitalization. Therapie (Paris) 50(3): 259-264
Jefferson, J.W. 1998: Drug interactions--friend or foe?. Journal of Clinical Psychiatry 59(Suppl): 37-47
Didkovskiĭ, N.A.; Reshetova, N.V.; Treskunov, V.K.; Malashenkova, I.K.; Sarsaniia, Z.S. 1996: Drug intolerance. Terapevticheskii Arkhiv 68(8): 48-53
Wallace, R.J.; Brown, B.A.; Griffith, D.E. 1993: Drug intolerance to high-dose clarithromycin among elderly patients. Diagnostic Microbiology and Infectious Disease 16(3): 215-221
Gunnarskog, J.; Källén, A.J. 1993: Drug intoxication during pregnancy: A study with central registries. Reproductive Toxicology 7(2): 117-121
Arai, K.; Ohsawa, M.; Kusu, F.; Takamura, K. 1993: Drug ion transfer across an oil-water interface and pharmacological activity. Bioelectrochemistry and Bioenergetics 31(1): 65-76
Costa, M.I.; Boldrini, J.L.; Bassanezi, R.C. 1995: Drug kinetics and drug resistance in optimal chemotherapy. Mathematical Biosciences 125(2): 191-209
Eros, I.; Takacs-Wormsdorff, T. 1997: Drug liberation from polymer-hydrogels. Part 1: Kinetics of the process. Pharmazie 52(4): 311-313
Lightfoot, T.C. 1998: Drug management in the palliative care of older people. Australian Journal of Hospital Pharmacy 28(1): 45-49
Rhie, J.K.; Hayashi, Y.; Welage, L.S.; Frens, J.; Wald, R.J.; Barnett, J.L.; Amidon, G.E.; Putcha, L.; Amidon, G.L.; Putcha, L.; Amidon, G.L. 1998: Drug marker absorption in relation to pellet size, gastric motility and viscous meals in humans. Pharmaceutical Research 15(2): 233-238
Chat, M.; Bayol-Denizot, C.; Suleman, G.; Roux, F.; Minn, A. 1998: Drug metabolizing enzyme activities and superoxide formation in primary and immortalized rat brain endothelial cells. Life Sciences 62(2): 151-163
Ranek, L.; Dalhoff, K.; Poulsen, H.E.; Brøsen, K.; Flachs, H.; Loft, S.; Wantzin, P. 1993: Drug metabolism and genetic polymorphism in subjects with previous halothane hepatitis. Scandinavian Journal of Gastroenterology 28(8): 677-680
Mitchell, S.C.; Waring, R.H.; Thorpe, W.V. 1997: Drug metabolism at Birmingham, England: the Thorpe years, 1927-68. Xenobiotica; the Fate of Foreign Compounds in Biological Systems 27(2): 127-146
Kern, A.; Bader, A.; Pichlmayr, R.; Sewing, K.F. 1997: Drug metabolism in hepatocyte sandwich cultures of rats and humans. Biochemical Pharmacology 54(7): 761-772
Teissier, E.; Fennrich, S.; Strazielle, N.; Daval, J.L.; Ray, D.; Schlosshauer, B.; Ghersi-Egea, J.F. 1998: Drug metabolism in in vitro organotypic and cellular models of mammalian central nervous system: activities of membrane-bound epoxide hydrolase and NADPH-cytochrome P-450 (c) reductase. Neurotoxicology 19(3): 347-355
Sonne, J. 1996: Drug metabolism in liver disease: implications for therapeutic drug monitoring. Therapeutic Drug Monitoring 18(4): 397-401
Guhe, C.; Degen, G.H.; Schuhmacher, U.S.; Kiefer, F.; Föllmann, W. 1996: Drug metabolizing enzyme activities in porcine urinary bladder epithelial cell cultures (PUBEC). Archives of Toxicology 70(10): 599-606
Batt, A.M.; Magdalou, J.; Vincent-Viry, M.; Ouzzine, M.; Fournel-Gigleux, S.; Galteau, M.M.; Siest, G. 1994: Drug metabolizing enzymes related to laboratory medicine: cytochromes P-450 and UDP-glucuronosyltransferases. Clinica Chimica Acta; International Journal of Clinical Chemistry 226(2): 171-190
Thomasin, C.; Hô, N.T.; Merkle, H.P.; Gander, B. 1998: Drug microencapsulation by PLA/PLGA coacervation in the light of thermodynamics. 1. Overview and theoretical considerations. Journal of Pharmaceutical Sciences 87(3): 259-268
Thomasin, C.; Merkle, H.P.; Gander, B. 1998: Drug microencapsulation by PLA/PLGA coacervation in the light of thermodynamics. 2. Parameters determining microsphere formation. Journal of Pharmaceutical Sciences 87(3): 269-275
Markovich, R.J.; Taylor, A.K.; Rosen, J. 1997: Drug migration from the adhesive matrix to the polymer film laminate facestock in a transdermal nitroglycerin system. Journal of Pharmaceutical and Biomedical Analysis 16(4): 651-660,.
Klee, H. 1995: Drug misuse and suicide: assessing the impact of HIV. Aids Care 7(Suppl): S145-S155
Lepore, D.A.; Knight, K.R.; Bhattacharya, S.; Ritz, M.; Robbins, S.P.; Sieg, P.; Morrison, W.A.; O'brien, B.M. 1994: Drug mixture which improves survival of ischemic rabbit epigastric skin flaps. Microsurgery 15(10): 685-692
da Motta, J.I.; Cunha, F.Q.; Vargaftig, B.B.; Ferreira, S.H. 1994: Drug modulation of antigen-induced paw oedema in guinea-pigs: Effects of lipopolysaccharide, tumour necrosis factor and leucocyte depletion. British Journal of Pharmacology 112(1): 111-116
Diquet, B.; Thomaré, P.; Bocquentin, M.; Diviné, C. 1993: Drug monitoring of clomipramine and desmethylclomipramine in depressed patients using a new liquid chromatographic assay. Biomedical Chromatography: Bmc 7(2): 59-63
Lehmann, E.; van der Crone, L.; Grobe-Einsler, R.; Linden, M. 1993: Drug monitoring study (phase IV) of xantinolnicotinate (Complamin) in general practice. Pharmacopsychiatry 26(2): 42-48
Barry, P.W.; O'Callaghan, C. 1998: Drug output from nebulizers is dependent on the method of measurement. European Respiratory Journal 12(2): 463-466
Malik, G.M.; Bilal, A.; Mekki, T.E.; Al-Kinany, H. 1996: Drug overdose in the Asir region of Saudi Arabia. Annals of Saudi Medicine 16(1): 33-36
Liversidge, G.G.; Conzentino, P. 1995: Drug particle size reduction for decreasing gastric irritancy and enhancing absorption of naproxen in rats. International Journal Of Pharmaceutics (amsterdam). 125(2): 309-313
González, E.; González, S. 1996: Drug photosensitivity, idiopathic photodermatoses, and sunscreens. Journal of the American Academy of Dermatology 35(6): 871
Warwick, J.A.; Corrall, R.J. 1998: Drug points: Serious interaction between warfarin and oral terbinafine. BMJ 316(7129): 440
Brooks, T.R. 1993: Drug prescribing for the elderly outpatient and for those confined to convalescent hospitals. How the new OBRA laws will change some established habits. Journal of the National Medical Association 85(12): 921-927
Zhan, S.K.; Tang, S.L.; Guo, Y.D.; Bloom, G. 1998: Drug prescribing in rural health facilities in China: implications for service quality and cost. Tropical Doctor 28(1): 42-48
Simon, N.; Hakkou, F.; Minani, M.; Jasson, M.; Diquet, B. 1998: Drug prescription and utilization in Morocco. Therapie 53(2): 113-120
Ekedahl, A.; Andersson, S.I.; Hovelius, B.; Mölstad, S.; Liedholm, H.; Melander, A. 1995: Drug prescription attitudes and behaviour of general practitioners. Effects of a problem-oriented educational programme. European Journal of Clinical Pharmacology 47(5): 381-387
Maggini, M.; Raschetti, R.; Traversa, G. 1996: Drug prescription in Italy. European Journal of Clinical Pharmacology 49(6): 429-430
Wändell, P.E.; Brorsson, B.; Aberg, H. 1997: Drug prescription in diabetic patients in Stockholm in 1992 and 1995--change over time. European Journal of Clinical Pharmacology 52(4): 249-254
Goubier-Vial, C.; Ferry, S.; Boissel, J.P. 1996: Drug prescription survey: Implantation in hospital. Journal de Pharmacie Clinique 15(SPEC. ISSUE): 78-80
Longshore, D.; Grills, C. 1998: Drug problem recognition among African American drug-using arrestees. Addictive Behaviors 23(2): 275-279
Lemmens Gruber, R.; Studenik, C.; Marei, H.; Heistracher, P. 1995: Drug profile of new benzofurane derivatives in guinea-pig isolated heart muscle preparations. Archives Internationales de Pharmacodynamie et de Therapie 330(2): 165-176
Kibwage, I.O.; Ogeto, J.O.; Maitai, C.K.; Rutere, G.; Thuranira, J.; Ochieng', A. 1992: Drug quality control work in Daru: observations during 1983-1986. East African Medical Journal 69(10): 577-580
Kenyon, T.A.; Kenyon, A.S.; Sibiya, T. 1994: Drug quality screening in developing countries: establishment of an appropriate laboratory in Swaziland. Bulletin of the World Health Organization 72(4): 615-620
Tiller, P.R.; Cunniff, J.; Land, A.P.; Schwartz, J.; Jardine, I.; Wakefield, M.; Lopez, L.; Newton, J.F.; Burton, R.D.; Folk, B.M.; Buhrman, D.L.; Price, P.; Wu, D. 1997: Drug quantitation on a benchtop liquid chromatography-tandem mass spectrometry system. Journal of Chromatography A 771(1-2): 119-125
Takayanagi, I.; Koike, K.; Satoh, M.; Okayasu, A. 1997: Drug receptor mechanisms in smooth muscle: beta-chloroethylamine-sensitive and -resistant receptor mechanisms. Japanese Journal of Pharmacology 73(1): 1-22
Plusquellec, Y.; Houin, G. 1992: Drug recirculation model with multiple cycles occurring at unequal time intervals. Journal of Biomedical Engineering 14(6): 521-526
Schmitt, B.; Netzer, R.; Fanconi, S.; Baumann, P.; Boltshauser, E. 1994: Drug refractory epilepsy in brain damage: effect of dextromethorphan on EEG in four patients. Journal of Neurology Neurosurgery and Psychiatry 57(3): 333-339
Hallas, J.; Harvald, B.; Worm, J.; Beck-Nielsen, J.; Gram, L.F.; Grodum, E.; Damsbo, N.; Schou, J.; Kromann-Andersen, H.; Frølund, F. 1993: Drug related hospital admissions. Results from an intervention program. European Journal of Clinical Pharmacology 45(3): 199-203
Sharma, V.K.; Dhar, S.; Gill, A.N. 1996: Drug related involvement of specific sites in fixed eruptions: a statistical evaluation. Journal of Dermatology 23(8): 530-534
Song, Y.; Onishi, H.; Machida, Y.; Nagai, T. 1996: Drug release and antitumor characteristics of N-succinyl-chitosan-mitomycin C as an implant. Journal of Controlled Release 42(1): 93-100
Zur Muehlen, A.; Mehnert, W. 1998: Drug release and release mechanism of prednisolone loaded solid lipid nanoparticles. Pharmazie 53(8): 552-555
Narisawa, S.; Nagata, M.; Ito, T.; Yoshino, H.; Hirakawa, Y.; Noda, K. 1995: Drug release behavior in gastrointestinal tract of beagle dogs from multiple unit type rate-controlled or time-controlled release preparations coated with insoluble polymer-based film. Journal of Controlled Release 33(2): 253-260
Huang, Y.Y.; Chung, T.W.; Tzeng, T.W. 1997: Drug release from PLA/PEG microparticulates. International Journal Of Pharmaceutics (amsterdam). 156(1): 9-15
Shieh, L.; Tamada, J.; Tabata, Y.; Domb, A.; Langer, R. 1994: Drug release from a new family of biodegradable polyanhydrides. Journal of Controlled Release 29(1-2): 73-82
Ferrero, M.C.; Velasco, M.V.; Munoz, A.; Jimenez-Castellanos, M.R.; Castellano, I.; Gurruchaga, M.; Goni, I. 1997: Drug release from a new family of graft copolymers of methyl methacrylate. I. International Journal of Pharmaceutics (Amsterdam) 149(2): 233-240
Otsuka, M.; Matsuda, Y.; Kokubo, T.; Yoshihara, S.; Nakamura, T.; Yamamuro, T. 1995: Drug release from a novel self-setting bioactive glass bone cement containing cephalexin and its physicochemical properties. Journal of Biomedical Materials Research 29(1): 33-38
Kubota, K.; Twizell, E.H.; Maibach, H.I. 1994: Drug release from a suspension with a finite dissolution rate: Theory and its application to a betamethasone 17-valerate patch. Journal of Pharmaceutical Sciences 83(11): 1593-1599
Sasaki, H.; Tei, C.; Nishida, K.; Nakamura, J. 1993: Drug release from an ophthalmic insert of a beta-blocker as an ocular drug delivery system. Journal of Controlled Release 27(2): 127-137
Kim, S.-Ho; Ha, J.-Hun; Jung, Y.-Jae; Cho, C.-Su 1995: Drug release from bioerodible hydrogels composed of poly-epsilon-caprolactone/poly(ethylene glycol) macromer semiinterpenetrating polymer network. Archives of Pharmacal Research 18(1): 18-21
Kim, C.J. 1995: Drug release from compressed hydrophilic POLYOX-WSR tablets. Journal of Pharmaceutical Sciences 84(3): 303-306
Lindner, W.D.; Lippold, B.C. 1995: Drug release from hydrocolloid embeddings with high or low susceptibility to hydrodynamic stress. Pharmaceutical Research 12(11): 1781-1785
Adikwu, Michael Umale 1997: Drug release from latex-treated, matrix tablet formulations. Acta Pharmaceutica 47(1): 31-37
Gayet, J.C.; Fortier, G. 1995: Drug release from new bioartificial hydrogel. Artificial Cells Blood Substitutes and Immobilization Biotechnology 23(5): 605-611
Miyazaki, S.; Nakayama, A.; Oda, M.; Takada, M.; Attwood, D. 1995: Drug release from oral mucosal adhesive tablets of chitosan and sodium alginate. International Journal Of Pharmaceutics (amsterdam). 118(2): 257-263
Järvinen, K.; Akerman, S.; Svarfvar, B.; Tarvainen, T.; Viinikka, P.; Paronen, P. 1998: Drug release from pH and ionic strength responsive poly(acrylic acid) grafted poly(vinylidenefluoride) membrane bags in vitro. Pharmaceutical Research 15(5): 802-805
Aikawa, K.; Mitsutake, N.; Uda, H.; Tanaka, S.; Shimamura, H.; Aramaki, Y.; Tsuchiya, S. 1998: Drug release from pH-response polyvinylacetal diethylaminoacetate hydrogel, and application to nasal delivery. International Journal Of Pharmaceutics (amsterdam). 168(2): 181-188, E 15
Vandelli, M.A.; Leo, E.; Foni, F.; Bernabei, M.T. 1998: Drug release from perforated matrices containing hydroxypropylcellulose. International Journal Of Pharmaceutics (amsterdam). 171(2): 165-175,. 15
Zatz, J.L. 1995: Drug release from semisolids: Effect of membrane permeability on sensitivity to product parameters. Pharmaceutical Research 12(5): 787-789
Ozdemir, N.; Ozalp, Y. 1995: Drug release from silicone matrices: I. Influence of formulation and shape factors. Farmaco 50(7-8): 549-554
Wan, L.S.C.; Heng, P.W.S.; Tan, Y.T.F. 1994: Drug release from spheroids coated with a mixture of HPMC-NaCMC. Chinese Pharmaceutical Journal 46(6): 491-504
Murthy, S.N.; Sateesh, M.; Hamsa, V. 1997: Drug release from terbutaline sulphate transdermal films across human cadaver skin. Indian Journal of Pharmaceutical Sciences 59(2): 75-76
Ohwaki, T.; Nakamura, M.; Ozawa, H.; Kawashima, Y.; Hino, T.; Takeuchi, H.; Niwa, T. 1993: Drug release from the water-in-oil-in-water multiple emulsion in vitro: II. Effects of the addition of hydrophilic surfactants to the internal aqueous compartment on the release rate of secretin. Chemical and Pharmaceutical Bulletin 41(4): 741-746
Ohwaki, T.; Nakamura, M.; Ozawa, H.; Kawashima, Y.; Hino, T.; Takeuchi, H.; Niwa, T. 1993: Drug release from water-in-oil-in-water multiple emulsions in vitro: Effects of the addition of hydrophilic surfactants to the internal aqueous compartment on the release rate of water-soluble drug. Yakuzaigaku 53(1): 44-54
Zhao, G.L.; Wang, H.C. 1995: Drug release kinetics of ibuprofen coated granules and their in vitro-in vivo correlation. Yao Xue Xue Bao 30(4): 291-297
O'connor, R.E.; Schwartz, J.B. 1993: Drug release mechanism from a microcrystalline cellulose pellet system. Pharmaceutical Research 10(3): 356-361
Luo, Y.; Zhuo, R.X.; Fan, C.L.e 1994: Drug release of biodegradable polyphosphate ester. Zhongguo Yiyao Gongye Zazhi 25(6): 267-289
Sato, H.; Ono, K.; Oka, M. 1994: Drug release through fibrinolysis of antibiotic-bound fibrin. Journal of Controlled Release 29(1-2): 125-132
Eckert, H. 1994: Drug research and development. Anales de la Real Academia de Farmacia 60(4): 599-614
Santi, P.; Colombo, P.; Bettini, R.; Catellani, P.L.; Minutello, A.; Volpato, N.M. 1997: Drug reservoir composition and transport of salmon calcitonin in transdermal iontophoresis. Pharmaceutical Research 14(1): 63-66
Iwahana, M.; Utoguchi, N.; Mayumi, T.; Goryo, M.; Okada, K. 1998: Drug resistance and P-glycoprotein expression in endothelial cells of newly formed capillaries induced by tumors. Anticancer Research 18(4c): 2977-2980
Gautam, A.R.; Ramteke, P.W.; Bhattacherjee, J.W. 1993: Drug resistance and curing pattern in enterotoxigenic non-O1 Vibrio cholerae isolated in a gastroenteritis outbreak. Journal of Environmental Science and Health Part A Environmental Science and Engineering 28(1): 99-104
Michowitz, M.; Dayan-Avidan, G.; Bar-Shira-Maymon, B.; Donin, N.; Leibovici, J. 1994: Drug resistance and its counteraction by cyclosporin A in function of metastatic potential in the Lewis lung carcinoma system. Cellular and Molecular Biology 40(4): 551-560
Okubo, T.; Okamoto, R.; Iyobe, S.; Takahashi, A.; Yomoda, S.; Inoue, M. 1994: Drug resistance and phage typing of clinical isolates of Staphylococcus aureus. Japanese Journal of Antibiotics 47(4): 357-364
Orrett, F.A. 1997: Drug resistance and plasmid profile of Shigella organisms from different outbreaks in Trinidad and Tobago in 1994. East African Medical Journal 74(3): 143-146
Eid, H.; Géczi, L.; Mágori, A.; Bodrogi, I.; Institoris, E.; Bak, M. 1998: Drug resistance and sensitivity of germ cell testicular tumors: evaluation of clinical relevance of MDR1/Pgp, p53, and metallothionein (MT) proteins. Anticancer Research 18(4c): 3059-3064
Kuritzkes, D.R.; Quinn, J.B.; Benoit, S.L.; Shugarts, D.L.; Griffin, A.; Bakhtiari, M.; Poticha, D.; Eron, J.J.; Fallon, M.A.; Rubin, M. 1996: Drug resistance and virologic response in NUCA 3001, a randomized trial of lamivudine (3TC) versus zidovudine (ZDV) versus ZDV plus 3TC in previously untreated patients. Aids 10(9): 975-981
Harnevo, L.E.; Agur, Z. 1992: Drug resistance as a dynamic process in a model for multistep gene amplification under various levels of selection stringency. Cancer Chemotherapy and Pharmacology 30(6): 469-476
Kolchinsky, A.; Roninson, I.B. 1997: Drug resistance conferred by MDR1 expression in spheroids formed by glioblastoma cell lines. Anticancer Research 17(5a): 3321-3327
Campeau, R.C.; Gulli, L.F.; Graves, J.F. 1996: Drug resistance in Detroit River gram-negative bacilli. Microbios 88(357): 205-212
Cole, S.T.; Telenti, A. 1995: Drug resistance in Mycobacterium tuberculosis. European Respiratory Journal. Supplement 20: 701s-713s
Butlin, C.R.; Neupane, K.D.; Failbus, S.S.; Morgan, A.; Britton, W.J. 1996: Drug resistance in Nepali leprosy patients. International Journal of Leprosy and other Mycobacterial Diseases: Official Organ of the International Leprosy Association 64(2): 136-141
Hoszowski, A.; Wasyl, D.; Truszczynski, M. 1998: Drug resistance in Salmonella strains isolated from animals and their feeds in Poland during 1994-1996. Medycyna Weterynaryjna 54(1): 33-37
Savicka, D.; Silhankova, L. 1995: Drug resistance in Yarrowia lipolytica. Folia Microbiologica 40(1): 89-94
Daugschies, A. 1996: Development of resistance to antiparasitic agents in parasites pathogenic to animals. Deutsche Tierärztliche Wochenschrift 103(7): 260-263
Pileggi, S.A.vim Veiga; Pileggi, M.; Azevedo, J.L.ci De 1994: Drug resistance in hospital strains of Pseudomonas. Arquivos de Biologia e Tecnologia 37(1): 77-89
Sood, A.K.; Buller, R.E. 1998: Drug resistance in ovarian cancer: From the laboratory to the clinic. Obstetrics and Gynecology 92(2): 312-319
Van de Vrie, W.; Van der Heyden, S.A.; Gheuens, E.E.; Bijma, A.M.; De Bruijn, E.A.; Marquet, R.L.; Van Oosterom, A.T.; Eggermont, A.M. 1993: Drug resistance in rat colon cancer cell lines is associated with minor changes in susceptibility to cytotoxic cells. Cancer Immunology Immunotherapy: Cii 37(5): 337-342
Davey, R.A.; Longhurst, T.J.; Davey, M.W.; Belov, L.; Harvie, R.M.; Hancox, D.; Wheeler, H. 1995: Drug resistance mechanisms and MRP expression in response to epirubicin treatment in a human leukaemia cell line. Leukemia Research 19(4): 275-282
Ribrag, V.; Massade, L.; Faussat, A.M.; Dreyfus, F.; Bayle, C.; Gouyette, A.; Marie, J.P. 1996: Drug resistance mechanisms in chronic lymphocytic leukemia. Leukemia 10(12): 1944-1949
Rudoi, N.M. 1996: Drug resistance of M. tuberculosis bacteria and its significance in the practice of tuberculosis hospital. Problemy Tuberkuleza 1996(3): 6-8
Havelkova, M.; Papezova, E.; Slosarek, M.; Kubin, M. 1994: Drug resistance of M. tuberculosis in Prague in 1987-1992. Epidemiologie Mikrobiologie Imunologie 43(4): 158-161
Pinto, W.P.; Hadad, D.J.; Palhares, M.C.; Ferrazoli, L.; Telles, M.A.; Ueki, S.Y.; Santos, M.T.; Placco, A.L.; Sauaia, N.; Palaci, M. 1996: Drug resistance of M. tuberculosis isolated from patients with HIV infection seen at an AIDS Reference Center in São Paulo, Brazil. Revista do Instituto de Medicina Tropical de Sao Paulo 38(1): 15-21
Angarano, G.; Carbonara, D.; Costa, D.; Group, T.-Italian-Tuberculosis-Drug-Resistance-Study 1995: Drug resistance of Mycobacterium tuberculosis strains isolated from HIV-infected Italian patients: Preliminary report from a multicentric study. Microbiologica 18(1): 69-72
Tokunaga, S.; Ohkawa, M.; Yamaguchi, K.; Nakashima, T.; Nishikawa, T.; Fujita, S. 1993: Drug resistance of coagulase-negative staphylococci from patients with urinary tract infection. International Urology and Nephrology 25(4): 315-320
Jiang, B.; Zhang, H.Q.; Xue, S.B. 1994: Drug resistance of doxorubicin-resistant CHO cell line. Zhongguo Yao Li Xue Bao 15(2): 189-192
Kussmann-Gerber, S.; Kuonen, O.; Folkers, G.; Pilger, B.D.; Scapozza, L. 1998: Drug resistance of herpes simplex virus type 1--structural considerations at the molecular level of the thymidine kinase. European Journal of Biochemistry 255(2): 472-481
Nagane, M.; Levitzki, A.; Gazit, A.; Cavenee, W.K.; Huang, H.J. 1998: Drug resistance of human glioblastoma cells conferred by a tumor-specific mutant epidermal growth factor receptor through modulation of Bcl-XL and caspase-3-like proteases. Proceedings of the National Academy of Sciences of the United States of America 95(10): 5724-5729
Hashimoto, H. 1994: Drug resistance of methicillin-resistant Staphylococcus aureus (MRSA) in Japan until 1993. Japanese Journal of Antibiotics 47(6): 575-584
Veelken, H.; Licht, T.; Lais, A.; Köhler, G.; Mertelsmann, R.; Schaefer, H.E.; Lübbert, M. 1998: Drug resistance of secondary acute myeloid leukemia with megakaryoblastic features and p190 BCR-ABL rearrangement. Leukemia Research 22(11): 1021-1027
Totake, K.; IIda, M.; Sato, H.; Oki, F.; Odaka, T. 1995: Drug resistance of staphylococci isolated in the Saitama medical school hospital. Journal of Saitama Medical School 22(1): 29-32
Girardi, E.; Antonucci, G.; Tronci, M.; Bordi, E.; Ippolito, G. 1996: Drug resistance patterns among tuberculosis patients in Rome, 1990-1992. Scandinavian journal of infectious diseases 28(5): 487-491
Chiang, I.H.; Yu, M.C.; Bai, K.J.; Wu, M.P.; Hsu, C.J.; Lin, T.P.; Luh, K.T. 1998: Drug resistance patterns of tuberculosis in Taiwan. Journal of the Formosan Medical Association 97(8): 581-583
Bhushan, A.; Kupperman, J.L.; Stone, J.E.; Kimberly, P.J.; Calman, N.S.; Hacker, M.P.; Birge, R.B.; Tritton, T.R.; Newell, M.K. 1998: Drug resistance results in alterations in expression of immune recognition molecules and failure to express Fas (CD95). Immunology and Cell Biology 76(4): 350-356
Motohashi, N.; Kurihara, T.; Kawase, M.; Hevér, A.; Tanaka, M.; Szabo, D.; Nacsa, J.; Yamanaka, W.; Kerim, A.; Molnár, J. 1997: Drug resistance reversal, anti-mutagenicity and antiretroviral effect of phthalimido- and chloroethyl-phenothiazines. Anticancer Research 17(5a): 3537-3543
Coley, H.M. 1997: Drug resistance studies using fresh human ovarian carcinoma and soft tissue sarcoma samples. Keio Journal of Medicine 46(3): 142-147
Eliopoulos, N.; Cournoyer, D.; Momparler, R.L. 1998: Drug resistance to 5-aza-2'-deoxycytidine, 2',2'-difluorodeoxycytidine, and cytosine arabinoside conferred by retroviral-mediated transfer of human cytidine deaminase cDNA into murine cells. Cancer ChemoTherapy and Pharmacology 42(5): 373-378
Kimura, M.; Tagawa, M.; Takenaga, K.; Nakagawara, A.; Horitsu, K.; Yamaguchi, T.; Saisho, H.; Sakiyama, S. 1997: Drug resistance to ganciclovir observed in suicide gene therapy is due to the loss of integrated herpes simplex virus-thymidine kinase gene. International Journal of Oncology 10(4): 775-778
Wolf, D.M.; Jordan, V.C.aig 1993: Drug resistance to tamoxifen during breast cancer therapy. Breast Cancer Research and Treatment 27(1-2): 27-40
Robert, J.; Larsen, A.K. 1998: Drug resistance to topoisomerase II inhibitors. Biochimie 80(3): 247-254
Hill, B.T. 1996: Drug resistance: An overview of the current state of the art. International Journal of Oncology 9(2): 197-203
D.K.ntor, I.N.; Latini, O.; Barrera, L. 1998: Drug resistant and multidrug resistant tuberculosis in Argentina and in other Latin American countries. Medicina (Buenos Aires) 58(2): 202-208
Massa, S.; Petruccioli, M.; Fanelli, M.; Gori, L. 1995: Drug resistant bacteria in non carbonated mineral waters. Microbiological Research 150(4): 403-408
Bradley, A.; Rea, H.; Vaughan, R.; Calder, L. 1994: Drug resistant tuberculosis in Auckland 1988-92. New Zealand Medical Journal 107(974): 99-101
Coninx, R.; Pfyffer, G.E.; Mathieu, C.; Savina, D.; Debacker, M.; Jafarov, F.; Jabrailov, I.; Ismailov, A.; Mirzoev, F.; de Haller, R.; Portaels, F. 1998: Drug resistant tuberculosis in prisons in Azerbaijan: case study. Bmj 316(7142): 1423-1425
Heiati, H.; Tawashi, R.; Phillips, N.C. 1998: Drug retention and stability of solid lipid nanoparticles containing azidothymidine palmitate after autoclaving, storage and lyophilization. Journal of Microencapsulation 15(2): 173-184
Singh, S.S.; Smith, K.M.; Brown, D.M. 1996: Drug retention following intravesical delivery of fluorouracil therapeutic adhesive in C3H mouse bladder. Anti-Cancer Drugs 7(5): 507-513
Krishan, A.; Fitz, C.M.; Andritsch, I. 1997: Drug retention, efflux, and resistance in tumor cells. Cytometry 29(4): 279-285,. 1
Bakke, O.M.; Manocchia, M.; de Abajo, F.; Kaitin, K.I.; Lasagna, L. 1995: Drug safety discontinuations in the United Kingdom, the United States, and Spain from 1974 through 1993: a regulatory perspective. Clinical Pharmacology and Therapeutics 58(1): 108-117
Edwards, J.G.; Inman, W.H.W.; Wilton, L.; Pearce, G.L.; Kubota, K. 1997: Drug safety monitoring of 12692 patients treated with fluoxetine. Human Psychopharmacology 12(2): 127-137
Graille, V.; Lapeyre-Mestre, M.; Montastruc, J.L. 1994: Drug safety: A survey among residents of a university hospital. Therapie 49(5): 451-454
de Zeeuw, R.A. 1997: Drug screening in biological fluids. The need for a systematic approach. Journal of Chromatography. B, Biomedical Sciences and Applications 689(1): 71-79
Skelton, H.; Dann, L.M.; Ong, R.T.; Hamilton, T.; Ilett, K.F. 1998: Drug screening of patients who deliberately harm themselves admitted to the emergency department. Therapeutic Drug Monitoring 20(1): 98-103
Winkler, S.; Brandts, C.; Wernsdorfer, W.H.; Graninger, W.; Bienzle, U.; Kremsner, P.G. 1994: Drug sensitivity of Plasmodium falciparum in Gabon. Activity correlations between various antimalarials. Tropical Medicine and Parasitology: Official Organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft für Technische Zusammenarbeit 45(3): 214-218
Pejsak, Z.; Tarasiuk, K.; Molenda, J. 1998: Drug sensitivity of bacteria isolated from pathologically changed lungs of pigs. Medycyna Weterynaryjna 54(1): 38-42
Gribaldo, L.; Piccirillo, M.; Casati, S.; Collotta, A.; Mineo, E.; Pessina, A. 1998: Drug sensitivity of granulocyte-macrophage precursors (GM-CFU) from fresh murine bone marrow and from long-term bone marrow cultures. Toxicology In Vitro 12(1): 39-45
Fujiwara, T.; Motoyama, T.; Ishihara, N.; Watanabe, H. 1994: Drug sensitivity of small cell gastrointestinal carcinoma. Acta Medica et Biologica 42(1): 1-5
Lin, M.Y.; Ang, S.K.; Cheng, K.C.; Wu, C.T. 1991: Drug sensitivity of the bacteria newly isolated from the bone marrow of the dead on arrival birds in Taiwan: Continue 2. Journal of the Chinese Society of Veterinary Science 17(2): 59-66
Jinnah, F.; Islam, M.S.; Rumi, M.A.; Morshed, M.G.; Huq, F. 1996: Drug sensitivity pattern of E. coli causing urinary tract infection in diabetic and non-diabetic patients. Journal of International Medical Research 24(3): 296-301
Katoch, R.C.; Sharma, M.; Sambyal, D.S.; Nagal, K.B. 1996: Drug sensitivity profile of pathogenic microbes isolated from clinical cases of human and animals. Indian Veterinary Medical Journal 20(4): 271-274
Lu, D.Y.; Xu, B. 1992: Drug sensitivity tests on human pulmonary adenocarcinoma xenograft transplanted into subrenal capsules of mice. Chinese Journal of Pharmaceuticals 23(10): 460-462
Vandel, P.; Bizouard, P.; Vandel, S.; David, M.; Nezelof, S.; Bonin, B.; Francois, T.; Bertschy, G.; Sechter, D. 1995: Drug side effects. An epidemiological study in a university hospital psychiatric ward. Therapie (Paris) 50(1): 67-72
Caiaffa, W.T.; Vlahov, D.; Graham, N.M.; Astemborski, J.; Solomon, L.; Nelson, K.E.; Muñoz, A. 1994: Drug smoking, Pneumocystis carinii pneumonia, and immunosuppression increase risk of bacterial pneumonia in human immunodeficiency virus-seropositive injection drug users. American Journal of Respiratory and Critical Care Medicine 150(6 Part 1): 1493-1498
McCleave, N.R. 1993: Drug smuggling by body packers. Detection and removal of internally concealed drugs. Medical Journal of Australia 159(11-12): 750-754
Hierholzer, J.; Cordes, M.; Tantow, H.; Keske, U.; Mäurer, J.; Felix, R. 1995: Drug smuggling by ingested cocaine-filled packages: Conventional x-ray and ultrasound. Abdominal Imaging 20(4): 333-338
Mittenbühler, K.; Loleit, M.; Baier, W.; Fischer, B.; Sedelmeier, E.; Jung, G.; Winkelmann, G.; Jacobi, C.; Weckesser, J.; Erhard, M.H.; Hofmann, A.; Bessler, W.; Hoffmann, P. 1997: Drug specific antibodies: T-cell epitope-lipopeptide conjugates are potent adjuvants for small antigens in vivo and in vitro. International Journal of Immunopharmacology 19(5): 277-287
Weingartner, H.J.; Putnam, F.; George, D.T.; Ragan, P. 1995: Drug state-dependent autobiographical knowledge. Experimental and Clinical Psychopharmacology 3(3): 304-307
Maes, J.H.; Van Rijn, C.M.; Vossen, J.M. 1996: Drug states as modulators of conditioned immobility in a latent discrimination procedure. European Journal of Pharmacology 309(2): 131-140
Ponomarenko, M.S. 1995: Drug store: Present and future. Farmatsevtychnyi Zhurnal (Kiev) 1995(1): 45-49
Chong, K.; Loughlin, T.; Moeder, C.; Perpall, H.J.; Thompson, R.; Grinberg, N.; Smith, G.B.; Bhupathy, M.; Bicker, G. 1996: Drug substance manufacture process control: Application of flow injection analysis and HPLC for monitoring an enantiospecific synthesis. Journal of Pharmaceutical and Biomedical Analysis 15(1): 111-121
Castot, A.; Djezzar, S.; Deleau, N.; Guillot, B.; Efthymiou, M.L. 1997: Drug surveillance of herbal medicines. Therapie 52(2): 97-103
Benvenuti, C.; Cavalli, E. 1995: Drug surveillance on oxatomide in the management of allergic bronchial asthma: A multicentre study two dosage schedules in 920 patients. Rivista di Patologia e Clinica 50(3): 167-186
Dias, F.; Michael, S.G.; Hoffner, S.E.; Martins, L.; Norberg, R.; Källenius, G. 1993: Drug susceptibility in Mycobacterium tuberculosis of a sample of patients in Guinea Bissau. Tubercle and Lung Disease: the Official Journal of the International Union Against Tuberculosis and Lung Disease 74(2): 129-130
Meless, H.; Abegaze, B. 1997: Drug susceptibility of Neisseria isolates from patients attending clinics for sexually transmitted diseases in Addis Ababa. East African Medical Journal 74(7): 447-449
Kimura, S.; Watanabe, A.; Takeuchi, M.; Nagata, M.; Nakamura, K.; Harada, M. 1998: Drug susceptibility of PCA in WBB6F1-W/Wv mice. Cellular and Molecular Life Sciences: Cmls 54(5): 456-460
Nakae, M.; Sugahara, Y.; Sasaki, H.; Yasui, H.; Imai, C.; Hasegawa, Y.; Osaka, K.; Shibasaki, K. 1998: Drug susceptibility of clinically isolated Helicobacter pylori. Japanese Journal of Antibiotics 51(4): 281-285
Chen, S.J.; Wang, C.H. 1997: Drug susceptibility of pathogenic strains of Escherichia coli isolated from chickens between 1991 and 1995. Journal of the Chinese Society of Veterinary Science 23(2): 89-94
Wolf, B.; Dinger, V.; Weiler, C.; Schwinde, A.; Scheipers, P.; Kraus, M. 1996: Drug targeting and metabolic investigations of cryoprepared tumor cells with analytical electron energy loss spectroscopy. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 17(4): 234-250
Page-Clisson, M.E.; Pinto-Alphandary, H.; Chachaty, E.; Couvreur, P.; Andremont, A. 1998: Drug targeting by polyalkylcyanoacrylate nanoparticles is not efficient against persistent Salmonella. Pharmaceutical Research 15(4): 544-549
Menei, P.; Benoit, J.P.; Boisdron-Celle, M.; Fournier, D.; Mercier, P.; Guy, G. 1994: Drug targeting into the central nervous system by stereotactic implantation of biodegradable microspheres. Neurosurgery 34(6): 1058-64; Discussion 1064
Wu, D.; Yang, J.; Pardridge, W.M. 1997: Drug targeting of a peptide radiopharmaceutical through the primate blood-brain barrier in vivo with a monoclonal antibody to the human insulin receptor. Journal of Clinical Investigation 100(7): 1804-1812
Kreuter, J. 1994: Drug targeting with nanoparticles. European Journal of Drug Metabolism and Pharmacokinetics 19(3): 253-256
Chakrabarti, P. 1997: Drug targets and drug resistance in mycobacteria. Proceedings of the National Academy of Sciences India, Section B, Biological Sciences 67(3-4): 169-179
Abreu, M.E.; Griffiths, R.R. 1996: Drug tasting may confound human drug discrimination studies. Psychopharmacology 125(3): 255-257
Feinauer, D., M.; Havlovic, S., J. 1993: Drug testing as a strategy to reduce occupational accidents: A longitudinal analysis. Journal of Safety Research 24(1): 1-7
DuPont, R.L.; Baumgartner, W.A. 1995: Drug testing by urine and hair analysis: complementary features and scientific issues. Forensic Science International 70(1-3): 63-76
Kintz, P. 1996: Drug testing in addicts: a comparison between urine, sweat, and hair. Therapeutic Drug Monitoring 18(4): 450-455
Blesa, R. 1995: Drug therapy. Journal of Neuropathology and Experimental Neurology 54(Suppl): 30s-31s
Molina, V.; Montz, R.; Martín-Loeches, M.; Jiménez-Vicioso, A.; Carreras, J.L.; Rubia, F.J. 1995: Drug therapy and cerebral perfusion in obsessive-compulsive disorder. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 36(12): 2234-2238
Cohen, M.A.; Davies, P.H. 1998: Drug therapy and hyperprolactinaemia. Adverse Drug Reaction Bulletin 1998(190): 723-726
Starck, M.; Albrecht, H.; Pöllmann, W.; Straube, A.; Dieterich, M. 1997: Drug therapy for acquired pendular nystagmus in multiple sclerosis. Journal of Neurology 244(1): 9-16
Schectman, G.; Hiatt, J. 1996: Drug therapy for hypercholesterolemia in patients with cardiovascular disease: Factors limiting achievement of lipid goals. American Journal of Medicine 100(2): 197-204
Wilson, T.W.; Quest, D.W. 1994: Drug therapy for hypertension: where we are, and where we might be heading. Canadian Journal of Public Health 85(Suppl): S48-S50
Pohl, K.; Moessner, J. 1997: Drug therapy for pain in chronic pancreatitis. A futile effort?. Acta Endoscopica 27(1): 7-11
Coumel, P.; Thomas, O.; Leenhardt, A. 1996: Drug therapy for prevention of atrial fibrillation. American Journal of Cardiology 77(3): 3a-9a
Riggs, B.L.; Melton, L.J.; O'Fallon, W.M. 1996: Drug therapy for vertebral fractures in osteoporosis: evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficacy. Bone 18(3 Suppl): 197s-201s
Kessler, S. 1996: Drug therapy in attention-deficit hyperactivity disorder. Southern Medical Journal 89(1): 33-38
Boettiger, B.W.; Fleischer, F. 1994: Drug therapy in coronary heart disease-perioperative implications. Anaesthesist 43(11): 699-717
Ng, Y.T.; Ouvrier, R.A.; Wu, T. 1998: Drug therapy in juvenile dermatomyositis: follow-up study. Journal of Child Neurology 13(3): 109-112
Sidel'nikova, V.M.; Kidralieva, A.S.; Mishchenko, A.L. 1993: Drug therapy in pregnant women with antiphospholipid syndrome. Khimiko-Farmatsevticheskii Zhurnal 27(2): 78-79
Jezdimirovic, M.; Cupic, V.; Trailovic, S.; Milovanovic, M. 1996: Drug therapy of gastro-intestinal tract diseases in piglets. Veterinarski Glasnik 50(1-2): 33-40
Worth, H.; Breuer, H.W.M. 1993: Drug therapy of pulmonary bleeding. Atemwegs- und Lungenkrankheiten 19(1): 14-17
Jezdimirovic, M.; Trailovic, D. 1994: Drug therapy of respiratory diseases in horses. Veterinarski Glasnik 48(8): 661-668
Parhofer, K.G.; Richter, W.O.; Schwandt, P. 1996: Drug therapy of severe hypercholesterolemia in patients with coronary artery disease. Artificial Organs 20(4): 286-291
Joffe, M.M.; Love, L.A.; Leff, R.L.; Fraser, D.D.; Targoff, I.N.; Hicks, J.E.; Plotz, P.H.; Miller, F.W. 1993: Drug therapy of the idiopathic inflammatory myopathies: Predictors of response to prednisone, azathioprine, and methotrexate and a comparison of their efficacy. American Journal of Medicine 94(4): 379-387
Mulder, C.J.; van den Hazel, S.J. 1998: Drug therapy: dose-response relationship of oral mesalazine in inflammatory bowel disease. Mediators of Inflammation 7(3): 135-136
Duthie, S.J.; Melvin, W.T.; Burke, M.D. 1995: Drug toxicity mechanisms in human hepatoma HepG2 cells: cyclosporin a and tamoxifen. Xenobiotica; the Fate of Foreign Compounds in Biological Systems 25(10): 1151-1164
Monro, A. 1994: Drug toxicokinetics: Scope and limitations that arise from species differences in pharmacodynamic and carcinogenic responses. Journal of Pharmacokinetics and Biopharmaceutics 22(1): 41-57
Phares, K.; Cho, M.; Johnson, K.; Swarbrick, J. 1995: Drug transport across nylon 610 films: Influence of synthesis variables. Pharmaceutical Research 12(2): 248-256
Dehouck, M.P.; Dehouck, B.; Schulep, C.; Lemaire, M.; Cecchelli, R. 1995: Drug transport to the brain: Comparison between in vitro and in vivo models of the blood-brain barrier. European Journal of Pharmaceutical Sciences 3(6): 357-365
Klingemann, H.K. 1996: Drug treatment in Switzerland: Harm reduction, decentralization and community response. Addiction 91(5): 723-736
Gorchein, A. 1997: Drug treatment in acute porphyria. British Journal of Clinical Pharmacology 44(5): 427-434,.
Mazzotta, G.; Paciaroni, M.; Sarchielli, P.; Caso, V.; Gallai, V. 1998: Drug treatment in headache of the developing age: Results of a multi-centre study. Giornale di Neuropsichiatria dell'Eta Evolutiva 18(1): 27-39
Quinn, N. 1995: Drug treatment of Parkinson's disease. British Medical Journal 310(6979): 575-579
Waldo, A.L.; Prystowsky, E.N. 1998: Drug treatment of atrial fibrillation in the managed care era. American Journal of Cardiology 81(5a): 23C-29C
Veldhuyzen van Zanten, S.J.; Cleary, C.; Talley, N.J.; Peterson, T.C.; Nyrén, O.; Bradley, L.A.; Verlinden, M.; Tytgat, G.N. 1996: Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials. American Journal of Gastroenterology 91(4): 660-673
Licht, R.W. 1998: Drug treatment of mania: A critical review. Acta Psychiatrica Scandinavica 97(6): 387-397
King, D.J. 1998: Drug treatment of the negative symptoms of schizophrenia. European Neuropsychopharmacology: the Journal of the European College of Neuropsychopharmacology 8(1): 33-42
Broome, K.M.; Knight, K.; Hiller, M.L.; Simpson, D.D. 1996: Drug treatment process indicators for probationers and prediction of recidivism. Journal of Substance Abuse Treatment 13(6): 487-491
Widdicombe, J. 1998: Drug uptake from the airways and lungs. Indian Journal of Physiology and Pharmacology 42(1): 3-14
Bernadotte, A.W.sborg, B.; Claesson, C.B.; Lundberg, O.; Thorslund, M. 1996: Drug usage and self-reported health among a cross-sectional population aged over 75 years. Clinical Drug Investigation 12(3): 156-169
Garriott, J.C. 1993: Drug use among homicide victims. Changing patterns. American Journal of Forensic Medicine and Pathology 14(3): 234-237
Eide, A.H.; Acuda, S.W. 1995: Drug use among secondary school students in Zimbabwe. Addiction 90(11): 1517-1527
Forster, L.M.; Tannhauser, M.; Barros, H.M. 1996: Drug use among street children in southern Brazil. Drug and Alcohol Dependence 43(1-2): 57-62
Baker, A.; Kochan, N.; Dixon, J.; Wodak, A.; Heather, N. 1994: Drug use and HIV risk-taking behaviour among injecting drug users not currently in treatment in Sydney, Australia. Drug and Alcohol Dependence 34(2): 155-160
Traversa, G.; Menniti-Ippolito, F.; Da Cas, R.; Mele, A.; Pulsoni, A.; Mandelli, F. 1998: Drug use and acute leukemia. Pharmacoepidemiology and Drug Safety 7(2): 113-123
van Kraaij, D.J.; Haagsma, C.J.; Go, I.H.; Gribnau, F.W. 1994: Drug use and adverse drug reactions in 105 elderly patients admitted to a general medical ward. Netherlands Journal of Medicine 44(5): 166-173
Darke, S.; Kaye, S.; Finlay-Jones, R. 1998: Drug use and injection risk-taking among prison methadone maintenance patients. Addiction 93(8): 1169-1175
Meier, C.R.; Jick, H. 1997: Drug use and pulmonary death rates in increasingly symptomatic asthma patients in the UK. Thorax 52(7): 612-617
Madianos, M.G.; Madianou-Gefou, D.; Stefanis, C.N. 1993: Drug use and somatic illnesses with psychological component: a nation-wide survey among adolescents and adults in Greece. PsychoTherapy and Psychosomatics 60(3-4): 177-185
Scivoletto, S.; Henriques, S.-Goncalves,. Jr.;; Andrade, A.-Guerra-De 1997: Drug use by adolescents who seek outpatient care: Comparison between crack and other illegal drugs: A pilot study. Revista ABP APAL (Associacao Brasileira de Psiquiatria Asociacion Psiquiatrica de la America Latina) 19(1): 7-17
Wills, P.; Claesson, C.B.; Fratiglioni, L.; Fastbom, J.; Thorslund, M.; Winblad, B. 1997: Drug use by demented and non-demented elderly people. Age and Ageing 26(5): 383-391
Garcia Lopez, J.A.; Blanco Gonzalez, M.I. 1997: Drug use by pharmacy students of the University of Granada. Farmacia Clinica 14(2): 90-97
Nobili, A.; Tettamanti, M.; Frattura, L.; Spagnoli, A.; Ferraro, L.; Marrazzo, E.; Ostino, G.; Comelli, M. 1997: Drug use by the elderly in Italy. Annals of PharmacoTherapy 31(4): 416-422
Robertson, M.J.; Zlotnick, C.; Westerfelt, A. 1997: Drug use disorders and treatment contact among homeless adults in Alameda County, California. American Journal of Public Health 87(2): 221-228
Hammerman, A.; Greenberg, A.; Yinnon, A.M. 1997: Drug use evaluation of ciprofloxacin: Impact of educational efforts on appropriateness of use. Journal of Clinical Pharmacy and Therapeutics 22(5-6): 415-420
Kouri, E.M.; Pope, H.G.; Powell, K.F.; Oliva, P.S.; Campbell, C. 1997: Drug use history and criminal behavior among 133 incarcerated men. American Journal of Drug and Alcohol Abuse 23(3): 413-419
Kiivet, R.A.; Bergman, U.; Rootslane, L.; Rägo, L.; Sjöqvist, F. 1998: Drug use in Estonia in 1994-1995: A follow-up from 1989 and comparison with two nordic countries. European Journal of Clinical Pharmacology 54(2): 119-124
Woo, J.; Ho, S.C.; Yuen, Y.K.; Lau, J. 1995: Drug use in an elderly Chinese population: prevalence and associated factors. Gerontology 41(2): 98-108
Sorensen, H.T.; Nielsen, G.L.; Andersen, A.M.N.; Zhou, W.J.; Steffensen, F.H.; Olesen, C.; Olsen, J. 1996: Drug use in pregnancy principal problems and a review of newer utilization studies. Clinical Research and Regulatory Affairs 13(3-4): 181-197
de Jong-van den Berg, L.T.; Waardenburg, C.M.; Haaijer-Ruskamp, F.M.; Dukes, M.N.; Wesseling, H. 1993: Drug use in pregnancy: A comparative appraisal of data collecting methods. European Journal of Clinical Pharmacology 45(1): 9-14
Harrison, L.D.; Kennedy, N.J. 1996: Drug use in the high intensity drug trafficking area of the US Southwest border. Addiction 91(1): 47-61
Avorn, J.; Gurwitz, J.H. 1995: Drug use in the nursing home. Annals of Internal Medicine 123(3): 195-204
Unikel, C.; Ortiz, A.; Vazquez, L. 1995: Drug use in the records of the Federal Hospital of Toxicomans. Fragments of the history of drug use in Mexico (1931-1948). Revista ABP APAL (Associacao Brasileira de Psiquiatria Asociacion Psiquiatrica de la America Latina) 17(3): 102-106
Unikel, C.; Ortiz, A.; Gonzalez, L.; Guerrero, A.-Lilia 1993: Drug use in the records of the Manicomia General de la Castaneda: Fragments of the history of pharmacodependence in Mexico 1866-1967. Revista ABP APAL (Associacao Brasileira de Psiquiatria Asociacion Psiquiatrica de la America Latina) 15(3): 75-81
Erickson, T.B.; Aks, S.E.; Koenigsberg, M.; Bunney, E.B.; Schurgin, B.; Levy, P. 1996: Drug use patterns at major rock concert events. Annals of Emergency Medicine 28(1): 22-26
Semla, T.P.; Cohen, D.; Paveza, G.; Eisdorfer, C.; Gorelick, P.; Luchins, D.; Hirschman, R.; Freels, S.; Levy, P.; Ashford, J.W. 1993: Drug use patterns of persons with Alzheimer's disease and related disorders living in the community. Journal of the American Geriatrics Society 41(4): 408-413
Stevens, M.; Youells, F.; Whaley, F.; Linsey, S. 1995: Drug use prevalence in a rural school-age population: the new Hampshire survey. American Journal of Preventive Medicine 11(2): 105-113
Isah, A.O.; Ohaju-Obodo, J.; Isah, E.C.; Ozemoya, O. 1997: Drug use profile in a Nigerian city hospital. Pharmacoepidemiology and Drug Safety 6(5): 319-324
Adu, A.; Taylor, S.; Armour, C.L. 1993: Drug use review contributes to more appropriate use of ceftazidime. Australian Journal of Hospital Pharmacy 23(3): 169-173
Drake, S.; Swift, W.; Hall, W.; Ross, M. 1993: Drug use, HIV risk-taking and psychosocial correlates of benzodiazepine use among methadone maintenance clients. Drug and Alcohol Dependence 34(1): 67-70
Rodriguez Salgado, D.; Rodriguez Alvarez, M. 1997: Drug users neuropsychological vulnerability to VIH-1 infection. Revista Espanola de Drogodependencias 22(3): 203-218
Kübler, D.; Hausser, D.; Joye, D. 1996: Drug users outside medical treatment: methodological and practical aspects. Sozial- und Praventivmedizin 41(Suppl 1): S96-104
Christo, G.; Franey, C. 1995: Drug users' spiritual beliefs, locus of control and the disease concept in relation to Narcotics Anonymous attendance and six-month outcomes. Drug and Alcohol Dependence 38(1): 51-56
Hindler, C.; Nazareth, I.; King, M.; Cohen, J.; Farmer, R.; Gerada, C. 1995: Drug users' views on general practitioners. Bmj 310(6975): 302
Haynes, P. 1998: Drug using offenders in south London. Trends and outcomes. Journal of Substance Abuse Treatment 15(5): 449-456
Nhachi, C.F.; Zvaraya, P.; Kasilo, J. 1994: Drug utilisation in the geriatric population in the nursing homes and central hospitals of urban Harare. Central African Journal of Medicine 40(5): 126-131
Bapna, J.S.; Tekur, U.; Gitanjali, B.; Shashindran, C.H.; Pradhan, S.C.; Thulasimani, M.; Tomson, G. 1992: Drug utilization at primary health care level in southern India. European Journal of Clinical Pharmacology 43(4): 413-415
Hershman, D.L.; Simonoff, P.A.; Frishman, W.H.; Paston, F.; Aronson, M.K. 1995: Drug utilization in the old old and how it relates to self-perceived health and all-cause mortality: results from the Bronx Aging Study. Journal of the American Geriatrics Society 43(4): 356-360
Srishyla, M.V.; Rani, M.A.N.ga; Venkataraman, B.V. 1994: Drug utilization of antimicrobials in the in-patient setting of a tertiary hospital. Indian Journal of Pharmacology 26(4): 282-287
Ferwerda, R.; De Jong Van Den Berg, L.T.W.; Van Den Berg, P.B.; Smilde, A.K. 1992: Drug utilization patterns in pregnancy. Journal of Pharmacoepidemiology 2(4): 35-52
Smith, H.A. 1992: Drug utilization review and the new medicaid requirements. Journal of Pharmacoepidemiology 2(4): 53-72
Rascati, K. 1995: Drug utilization review of concomitant use of specific serotonin reuptake inhibitors or clomipramine with antianxiety/sleep medications. Clinical Therapeutics 17(4): 786-790
Marschner, J.P.; Thürmann, P.; Harder, S.; Rietbrock, N. 1994: Drug utilization review on a surgical intensive care unit. International Journal of Clinical Pharmacology and Therapeutics 32(9): 447-451
Rupp, H.; Maisch, B.; Brilla, C.G. 1996: Drug withdrawal and rebound hypertension: Differential action of the central antihypertensive drugs moxonidine and clonidine. Cardiovascular Drugs and Therapy 10(Suppl): 251-262
Metten, P.; Belknap, J.K.; Crabbe, J.C. 1998: Drug withdrawal convulsions and susceptibility to convulsants after short-term selective breeding for acute ethanol withdrawal. Behavioural Brain Research 95(1): 113-122
Gratton, A.; Wise, R.A. 1994: Drug- and behavior-associated changes in dopamine-related electrochemical signals during intravenous cocaine self-administration in rats. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 14(7): 4130-4146
Brown, G.R.; Greenwood, J.K. 1994: Drug- and nutrition-induced hypophosphatemia: mechanisms and relevance in the critically ill. Annals of Pharmacotherapy 28(5): 626-632
Bailly, C.; Hénichart, J.P.; Colson, P.; Houssier, C. 1992: Drug-DNA sequence-dependent interactions analysed by electric linear dichroism. Journal of Molecular Recognition: Jmr 5(4): 155-171
Lenler-Petersen, P.; Hansen, D.; Andersen, M.; Sørensen, H.T.; Bille, H. 1995: Drug-Related Fatal Anaphylactic Shock in Denmark 1968-1990. A Study Based on Notifications to the Committee on Adverse Drug Reactions. Journal of Clinical Epidemiology 48(9): 1185-1188
Pastolero, G.C.; Asa, S.L. 1994: Drug-related pigmentation of the thyroid associated with papillary carcinoma. Archives of Pathology and Laboratory Medicine 118(1): 79-83
Herwig, S.; Su, Q.; Tempst, P. 1998: Drug-activated multiple pathways of defensin mRNA regulation in HL-60 cells are defined by reversed roles of participating protein kinases. Leukemia Research 22(10): 913-925
Senor, C.B.; Rodriguez Balleteros, J.; Gonzalez Infante, J.M. 1997: Drug-addiction and creativity. Psiquis 18(1): 56-60
Awong, I.E.; Dandurand, K.R.; Keeys, C.A.; Maung-Gyi, F.A. 1996: Drug-associated Guillain-Barré syndrome: a literature review. Annals of Pharmacotherapy 30(2): 173-180
Srivastava, M.; Perez-Atayde, A.; Jonas, M.M. 1998: Drug-associated acute-onset vanishing bile duct and Stevens-Johnson syndromes in a child. Gastroenterology 115(3): 743-746
Ahmed M el-B 1997: Drug-associated admissions to a district hospital in Saudi Arabia. Journal of Clinical Pharmacy and Therapeutics 22(1): 61-66
van der Klauw, M.M.; Wilson, J.H.; Stricker, B.H. 1998: Drug-associated agranulocytosis: 20 years of reporting in the Netherlands (1974-1994). American Journal of Hematology 57(3): 206-211
van der Klauw, M.M.; Wilson, J.H.; Stricker, B.H. 1996: Drug-associated anaphylaxis: 20 years of reporting in the Netherlands (1974-1994) and review of the literature. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 26(12): 1355-1363
Dhondt, A.D.F.; Hooijer, C.; Smit, J.H.; Van-Tilburg, W. 1996: Drug-associated depression is not major depressive disorder: A pilot study in a population-based sample of the elderly. International Journal of Geriatric Psychiatry 11(2): 141-148
Wang, D.Y.; Forslund, C.; Persson, U.; Wiholm, B.E. 1998: Drug-attributed anaphylaxis. Pharmacoepidemiology and Drug Safety 7(4): 269-274
Liao, J.S.; Reiss, W.G. 1996: Drug-cytokine interactions: Focus on cyclosporine. Pharmacotherapy 16(3): 401-408
Seager, H. 1998: Drug-delivery products and the Zydis fast-dissolving dosage form. Journal of Pharmacy and Pharmacology 50(4): 375-382
Goldberg, R.M.; Mabee, J.; Chan, L.; Wong, S. 1996: Drug-drug and drug-disease interactions in the ED: analysis of a high-risk population. American Journal of Emergency Medicine 14(5): 447-450
Schechter, M.D. 1997: Drug-drug discrimination: stimulus properties of drugs of abuse upon a serotonergic-dopaminergic continuum. Pharmacology Biochemistry and Behavior 56(1): 89-96
Ereshefsky, L. 1996: Drug-drug interactions involving antidepressants: focus on venlafaxine. Journal of Clinical Psychopharmacology 16(3 Suppl 2): 37s-50s; Discussion 50s-53s
Doucet, J.; Chassagne, P.; Trivalle, C.; Landrin, I.; Pauty, M.D.; Kadri, N.; Ménard, J.F.; Bercoff, E. 1996: Drug-drug interactions related to hospital admissions in older adults: a prospective study of 1000 patients. Journal of the American Geriatrics Society 44(8): 944-948
Koley, A.P.; Robinson, R.C.; Markowitz, A.; Friedman, F.K. 1997: Drug-drug interactions: effect of quinidine on nifedipine binding to human cytochrome P450 3A4. Biochemical Pharmacology 53(4): 455-460
Ong, J., T.H.; Chowhan, Z., T.; Samuels, G., J. 1993: Drug-excipient interactions resulting from powder mixing: VI. Role of various surfactants. International Journal of Pharmaceutics 96(1-3): 231-242
Easdon, C.M.; Vogel-Sprott, M. 1996: Drug-free behavioral history affects social drinkers' tolerance to a challenge dose of alcohol. Journal of Studies on Alcohol 57(6): 591-597
Rozas, G.; Labandeira García, J.L. 1997: Drug-free evaluation of rat models of parkinsonism and nigral grafts using a new automated rotarod test. Brain Research 749(2): 188-199
Cicogni, A.; Godi, F.; Perone, R.; Checcucci, A.; Lampronti, V.; Velicogna, F.; Zazo, M. 1996: Drug-free period and symptoms of depression in opiate addicts treated in a therapeutic community or in an outpatient setting. Alcoholism 32(2): 119-124
Finelli, P.F. 1992: Drug-induced Creutzfeldt-Jakob like syndrome. Journal of Psychiatry and Neuroscience: Jpn 17(3): 103-105
Tsuruoka, S.; Sugimoto, K.; Fujimura, A. 1998: Drug-induced Cushing syndrome in a patient with ulcerative colitis after betamethasone enema: evaluation of plasma drug concentration. Therapeutic Drug Monitoring 20(4): 387-389
Blommaert, F.A.; Michael, C.; Terheggen, P.M.; Muggia, F.M.; Kortes, V.; Schornagel, J.H.; Hart, A.A.; den Engelse, L. 1993: Drug-induced DNA modification in buccal cells of cancer patients receiving carboplatin and cisplatin combination chemotherapy, as determined by an immunocytochemical method: interindividual variation and correlation with disease response. Cancer Research 53(23): 5669-5675
Merello, M.; Starkstein, S.; Petracca, G.; Cataneo, E.A.; Manes, F.; Leiguarda, R. 1996: Drug-induced parkinsonism in schizophrenic patients: motor response and psychiatric changes after acute challenge with L-Dopa and apomorphine. Clinical Neuropharmacology 19(5): 439-443
Gilmour, E.; Chalmers, R.J.; Rowlands, D.J. 1995: Drug-induced Sweet's syndrome (acute febrile neutrophilic dermatosis) associated with hydralazine. British Journal of Dermatology 133(3): 490-491
Gharaibeh, M.; Zmeili, S.; Abu-Rajab, A.; Daoud, Z. 1998: Drug-induced admissions to medical wards at Jordan University Hospital. International Journal of Clinical Pharmacology and Therapeutics 36(9): 478-482
Kasantikul, D. 1998: Drug-induced akathisia and suicidal tendencies in psychotic patients. Journal of the Medical Association of Thailand 81(7): 551-554
Thickett, D.R.; Millar, A.B. 1997: Drug-induced antisynthetase syndrome. Postgraduate Medical Journal 73(857): 165-166
Boutroy, M.J. 1994: Drug-induced apnea. Biology of the Neonate 65(3-4): 252-257
Thomas, A.; El Rouby, S.; Reed, J.C.; Krajewski, S.; Silber, R.; Potmesil, M.; Newcomb, E.W. 1996: Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: relationship between p53 gene mutation and bcl-2/bax proteins in drug resistance. Oncogene 12(5): 1055-1062
Müller, M.; Strand, S.; Hug, H.; Heinemann, E.M.; Walczak, H.; Hofmann, W.J.; Stremmel, W.; Krammer, P.H.; Galle, P.R. 1997: Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. Journal of Clinical Investigation 99(3): 403-413
Borner, M.M.; Myers, C.E.; Sartor, O.; Sei, Y.; Toko, T.; Trepel, J.B.; Schneider, E. 1995: Drug-induced apoptosis is not necessarily dependent on macromolecular synthesis or proliferation in the p53-negative human prostate cancer cell line PC-3. Cancer Research 55(10): 2122-2128
Poersch, M.; Hufnagel, A.; Smolenski, C. 1996: Drug-induced asterixis amplified by relative hypoglycemia. Der Nervenarzt 67(4): 323-326
Hoigné, R.V.; Braunschweig, S.; Zehnder, D.; Kuenzi, U.P.; Hess, T.; Leuenberger, P. 1997: Drug-induced attack of bronchial asthma in inpatients: A 20-year survey of the Comprehensive Hospital Drug Monitoring Programme on adverse drug reactions, Berne/St. Gallen. European Journal of Clinical Pharmacology 53(1): 81-82
Vial, T.; Nicolas, B.; Descotes, J. 1997: Drug-induced autoimmunity: Experience of the French Pharmacovigilance system. Toxicology 119(1): 23-27
Colombati, S.; Pasanisi, P.; Losavio, P. 1994: Drug-induced cataracts: A case report on the use of methimazole. Annali di Ottalmologia e Clinica Oculistica 120(11): 677-680
Herpin, D.; Ragot, S.; Vaïsse, B.; Ferrandis, J.; Baguet, J.P.; Mallion, J.M.; Poggi, L.; Demange, J. 1996: Drug-induced changes in ambulatory blood pressure and pulse pressure in patients with or without sustained hypertension. Therapie 51(1): 11-17
Gekeler, V.; Beck, J.; Noller, A.; Wilisch, A.; Frese, G.; Neumann, M.; Handgretinger, R.; Ehninger, G.; Probst, H.; Niethammer, D. 1994: Drug-induced changes in the expression of MDR-associated genes: Investigations on cultured cell lines and chemotherapeutically treated leukemias. Annals of Hematology 69(Suppl): S19-S24
Prete, S.P.; Aquino, A.; Masci, G.; Orlando, L.; Giuliani, A.; De Santis, S.; De Vecchis, L.; De Filippi, R.; Greiner, J.W.; Bonmassar, E.; Graziani, G. 1996: Drug-induced changes of carcinoembryonic antigen expression in human cancer cells: effect of 5-fluorouracil. Journal of Pharmacology and Experimental Therapeutics 279(3): 1574-1581
Ali, S.F.; Kordsmeier, K.J.; Gough, B. 1995: Drug-induced circling preference in rats. Correlation with monoamine levels. Molecular Neurobiology 11(1-3): 145-154
Croci, T.; Landi, M.; Bianchetti, A.; Manara, L. 1995: Drug-induced defaecation in rats: role of central 5-HT1A receptors. British Journal of Pharmacology 115(1): 203-209
Taniguchi, K.; Kohno, K.; Kawanami, K.; Wada, M.; Kanematsu, T.; Kuwano, M. 1996: Drug-induced down-regulation of topoisomerase i in human epidermoid cancer cells resistant to saintopin and camptothecins. Cancer Research 56(10): 2348-2354
Fujita, Y.; Iwamoto, Y.; Okuyama, K.; Tanaka, K.; Maeda, T.; Sugioka, Y. 1994: Drug-induced endothelial injury potentiates lung colonization in a murine fibrosarcoma model. International Journal of Oncology 4(6): 1305-1310
Teraki, Y.; Moriya, N.; Shiohara, T. 1994: Drug-induced expression of intercellular adhesion molecule-1 on lesional keratinocytes in fixed drug eruption. American Journal of Pathology 145(3): 550-560
Seymour, R.A. 1993: Drug-induced gingival overgrowth. Adverse Drug Reactions and Toxicological Reviews 12(4): 215-232
Fischer, J. 1996: Drug-induced glycosaminoglycan storage: Dose-dependent changes in the pattern of accumulated glycosaminoglycans in cultured bovine and human fibroblasts. Biochemical Pharmacology 52(9): 1331-1337
Bublin, J.G.; Thompson, D.F. 1992: Drug-induced hair colour changes. Journal of Clinical Pharmacy and Therapeutics 17(5): 297-302
Maulik, N.; Engelman, R.M.; Wei, Z.; Liu, X.; Rousou, J.A.; Flack, J.E.; Deaton, D.W.; Das, D.K. 1995: Drug-induced heat-shock preconditioning improves postischemic ventricular recovery after cardiopulmonary bypass. Circulation 92(9): II381-II388
Farrell, G.C. 1997: Drug-induced hepatic injury. Journal of Gastroenterology and Hepatology 12(9-10): S242-S250,.
Bauer, T.M.; Bircher, A.J. 1997: Drug-induced hepatocellular liver injury due to benzylpenicillin with evidence of lymphocyte sensitization. Journal of Hepatology 26(2): 429-432
Pinson, D.M.; Havu, N.; Sztern, M.I.; Mattsson, H.; Looney, G.A.; Kimler, B.F.; Hurwitz, A. 1995: Drug-induced hypergastrinemia: Absence of trophic effects on colonic carcinoma in rats. Gastroenterology 108(4): 1068-1074
Pereira, S.P.; Gainsborough, N.; Dowling, R.H. 1998: Drug-induced hypochlorhydria causes high duodenal bacterial counts in the elderly. Alimentary Pharmacology and Therapeutics 12(1): 99-104
Cunningham, C.L.; Niehus, J.S. 1993: Drug-induced hypothermia and conditioned place aversion. Behavioral Neuroscience 107(3): 468-479
Kirsch, M. 1994: Drug-induced ileal disease: a new entity in the differential diagnosis of Crohn's disease. Southern Medical Journal 87(4): 546-548
Magro, C.M.; Crowson, A.N. 1996: Drug-induced immune dysregulation as a cause of atypical cutaneous lymphoid infiltrates: a hypothesis. Human Pathology 27(2): 125-132
Pellegatta, F.; Lu, Y.; Radaelli, A.; Zocchi, M.R.; Ferrero, E.; Chierchia, S.; Gaja, G.; Ferrero, M.E. 1996: Drug-induced in vitro inhibition of neutrophil-endothelial cell adhesion. British Journal of Pharmacology 118(3): 471-476
Lüllmann-Rauch, R. 1994: Drug-induced intralysosomal storage of sulfated glycosaminoglycans (GAGs): a methodical pitfall occurring with acridine derivatives. Experimental and Toxicologic Pathology: Official Journal of the Gesellschaft für Toxikologische Pathologie 46(4-5): 315-322
Nishikawa, T.; Munakata, K. 1997: Drug-induced laryngospasm. Masui. Japanese Journal of Anesthesiology 46(2): 276-278
Kuechle, M.K.; Stegemeir, E.; Maynard, B.; Gibson, L.E.; Leiferman, K.M.; Peters, M.S. 1994: Drug-induced linear IgA bullous dermatosis: report of six cases and review of the literature. Journal of the American Academy of Dermatology 30(2 Pt 1): 187-192
Wakelin, S.H.; Allen, J.; Zhou, S.; Wojnarowska, F. 1998: Drug-induced linear IgA disease with antibodies to collagen VII. British Journal of Dermatology 138(2): 310-314
Paul, C.; Wolkenstein, P.; Prost, C.; Caux, F.; Rostoker, G.; Heller, M.; Wechsler, J.; Revuz, J.; Roujeau, J.C. 1997: Drug-induced linear IgA disease: Target antigens are heterogeneous. British Journal of Dermatology 136(3): 406-411
Schapira, L. 1997: Drug-induced lung disease: Amiodarone. Prensa Medica Argentina 84(7): 751-753
Hollinger, M.A. 1993: Drug-induced lung toxicity. Journal of the American College of Toxicology 12(1): 31-47
Handrock, K.; Lüllmann-Rauch, R.; Vogt, R.D. 1993: Drug-induced lysosomal storage of sulfated glycosaminoglycans. Studies on the underlying structure-activity relationships. Toxicology 85(2-3): 199-213
Fischer, J.; Lüllmann, H.; Lüllmann-Rauch, R. 1996: Drug-induced lysosomal storage of sulphated glycosaminoglycans. General Pharmacology 27(8): 1317-1324
Kelly, W.A.; Marler, R.J.; Weikel, J.H. 1993: Drug-induced mesovarial leiomyomas in the rat: A review and additional data. Journal of the American College of Toxicology 12(1): 13-22
Radomirov, R.; Mutafova-Yambolieva, V. 1992: Drug-induced modulation of endothelin-1 effects on the tone of electrically stimulated rat vas deferens. Archives Internationales de Pharmacodynamie et de Therapie 318: 86-96
Aizawa, Y.; Chinushi, M.; Naitoh, N.; Shibata, A. 1996: Drug-induced narrowing of the width of the zone of entrainment as a predictor of the subsequent non-inducibility of reentrant ventricular tachycardia after an additional dose of an antiarrhythmic drug. Heart 75(2): 165-170
Clemens, J.A.; Stephenson, D.T.; Yin, T.; Smalstig, E.B.; Panetta, J.A.; Little, S.P. 1998: Drug-induced neuroprotection from global ischemia is associated with prevention of persistent but not transient activation of nuclear factor-kappaB in rats. Stroke 29(3): 677-682
Irvine, A.E.; French, A.; Daly, A.; Ranaghan, L.; Morris, T.C. 1994: Drug-induced neutropenia due to direct effects on CFU-C--ten years of culture experience. European Journal of Haematology 52(1): 21-27
Anders, N.; Wollensak, J. 1994: Drug-induced ocular pseudopemphigoid. Klinische Monatsblaetter fuer Augenheilkunde 205(2): 61-64
Kakigi, T.; Gao, X.M.; Tamminga, C.A. 1995: Drug-induced oral dyskinesias in rats after traditional and new neuroleptics. Journal of Neural Transmission. General Section 101(1-3): 41-49
Pavletic, Z.S.; Bishop, M.R.; Markopoulou, K.; Wszolek, Z.K. 1996: Drug-induced parkinsonism after allogeneic bone marrow transplantation. Bone Marrow Transplantation 17(6): 1185-1187
Chabolla, D.R.; Maraganore, D.M.; Ahlskog, J.E.; O'Brien, P.C.; Rocca, W.A. 1998: Drug-induced parkinsonism as a risk factor for Parkinson's disease: a historical cohort study in Olmsted County, Minnesota. Mayo Clinic Proceedings 73(8): 724-727
Suzuki, Y.; Hosokawa, K.; Atsumi, Y.; Asahina, T.; Shimada, A.; Murata, C.; Matsuoka, K. 1997: Drug-induced parkinsonism in diabetes. Report of two cases. Journal of the Japan Diabetes Society 40(5): 299-303
Montastruc, J.L.; Llau, M.E.; Rascol, O.; Senard, J.M. 1994: Drug-induced parkinsonism: A review. Fundamental and Clinical Pharmacology 8(4): 293-306
Llau, M.E.; Nguyen, L.; Senard, J.M.; Rascol, O.; Montastruc, J.L. 1994: Drug-induced parkinsonian syndromes: a 10-year experience at a regional center of pharmaco-vigilance. Revue Neurologique (Paris) 150(11): 757-762
Launhardt, H.; Hinnen, A.; Munder, T. 1998: Drug-induced phenotypes provide a tool for the functional analysis of yeast genes. Yeast 14(10): 935-942
Oshitani, N.; Matsumoto, T.; Moriyama, Y.; Kudoh, S.; Hirata, K.; Kuroki, T. 1998: Drug-induced pneumonitis caused by sulfamethoxazole, trimethoprim during treatment of Pneumocystis carinii pneumonia in a patient with refractory ulcerative colitis. Journal of Gastroenterology 33(4): 578-581
Callot, V.; Roujeau, J.C.; Bagot, M.; Wechsler, J.; Chosidow, O.; Souteyrand, P.; Morel, P.; Dubertret, L.; Avril, M.F.; Revuz, J. 1996: Drug-induced pseudolymphoma and hypersensitivity syndrome. Two different clinical entities. Archives of Dermatology 132(11): 1315-1321
Pathak, P.; McLachlan, R.S. 1998: Drug-induced pseudolymphoma secondary to lamotrigine. Neurology 50(5): 1509-1510
Thompson, D.F.; Gales, M.A. 1996: Drug-induced pure red cell aplasia. Pharmacotherapy 16(6): 1002-1008
Pranzatelli, M., R.; Razi, P. 1994: Drug-induced regulation of (125I)iodocyanopindolol-labeled 5-hydroxytryptamine-1B receptor binding sites in the central nervous system. Neuropsychopharmacology 10(4): 259-264
Celdran Hernandez, M.A.; Fuentes, D.F.utos, M.J.; Tovar, D.C.uz, J.M.; Andres Navarro, N.; Gavira Moreno, R.; Ruiz Ruiz, M.D.; Lopez Arranz, M.C. 1997: Drug-induced renal toxicity mechanism. Farmacia Clinica 14(9): 599-615
Loewenstein, A.; Zemel, E.; Lazar, M.; Perlman, I. 1993: Drug-induced retinal toxicity in albino rabbits: the effects of imipenem and aztreonam. IOVS Investigative Ophthalmology and Visual Science 34(12): 3466-3476
Lavrovsky, V.; Dong, Z.; Ma, W.Y.; Colburn, N. 1996: Drug-induced reversion of progression phenotype is accompanied by reversion of AP-1 phenotype in JB6 cells. In Vitro Cellular and Developmental Biology. Animal 32(4): 234-237
Kurumaji, Y.; Shono, M. 1994: Drug-induced solar urticaria due to repirinast. Dermatology 188(2): 117-121
Toepfer, M.; Sitter, T.; Lochmüller, H.; Pongratz, D.; Müller-Felber, W. 1998: Drug-induced systemic lupus erythematosus after 8 years of treatment with carbamazepine. European Journal of Clinical Pharmacology 54(2): 193-194
Pedersen-Bjergaard, U.; Andersen, M.; Hansen, P.B. 1997: Drug-induced thrombocytopenia: Clinical data on 309 cases and the effect of corticosteroid therapy. European Journal of Clinical Pharmacology 52(3): 183-189
Hsieh, M.H.; Chen, S.A.; Chiang, C.E.; Tai, C.T.; Lee, S.H.; Wen, Z.C.; Chang, M.S. 1996: Drug-induced torsades de pointes in one patient with congenital long QT syndrome. International Journal of Cardiology 54(1): 85-88
Postel, E.A.; Assalian, A.; Epstein, D.L. 1996: Drug-induced transient myopia and angle-closure glaucoma associated with supraciliary choroidal effusion. American Journal of Ophthalmology 122(1): 110-112
Moreau, C.; Sulpice, J.C.; Devaux, P.F.; Zachowski, A. 1997: Drug-induced transmembrane lipid scrambling in erythrocytes and in liposomes requires the presence of polyanionic phospholipids. Molecular Membrane Biology 14(1): 5-12
Starr, S.; Kozell, L.B.; Neve, K.A. 1995: Drug-induced up-regulation of dopamine D2 receptors on cultured cells. Journal of Neurochemistry 65(2): 569-577
Gherardini, G.; Gürlek, A.; Cromeens, D.; Joly, G.A.; Wang, B.G.; Evans, G.R. 1998: Drug-induced vasodilation: In vitro and in vivo study on the effects of lidocaine and papaverine on rabbit carotid artery. Microsurgery 18(2): 90-96
D'Atri, S.; Bonmassar, L.; Turriziani, M.; Giuliani, A. 1994: Drug-mediated changes in the susceptibility of human lymphoblastoid B cells to NK-mediated cytolysis: studies with a triazene compound. Journal of ChemoTherapy 6(5): 328-336
Murray, M. 1997: Drug-mediated inactivation of cytochrome P450. Clinical and Experimental Pharmacology and Physiology 24(7): 465-470
Steinberg, P.; Steinbrecher, R.; Schrenk, D.; Munzel, P.; Bruck, M.; Gschaidmaier, H.; Oesch, F.; Bock, K.W. 1994: Drug-metabolizing enzyme activities in freshly isolated oval cells and in an established oval cell line from carcinogen-fed rats. Cell Biology and Toxicology 10(1): 59-65
Brøsen, K. 1996: Drug-metabolizing enzymes and therapeutic drug monitoring in psychiatry. Therapeutic Drug Monitoring 18(4): 393-396
Nebert, D.W. 1994: Drug-metabolizing enzymes in ligand-modulated transcription. Biochemical Pharmacology 47(1): 25-37
Ullrich, D.; Muenzel, P.A.; Beck Gschaidmeier, S.; Schroeder, M.; Bock, K.W.lter 1997: Drug-metabolizing enzymes in pharyngeal mucosa and in oropharyngeal cancer tissue. Biochemical Pharmacology 54(10): 1159-1162,. 15
Peterson, T.C.; Rowden, G. 1998: Drug-metabolizing enzymes in rat liver myofibroblasts. Biochemical Pharmacology 55(5): 703-708
Homeida, A.M.; Al Eknah, M.M.; Dafalla, E.A. 1993: Drug-metabolizing enzymes in the placenta and foetus of camel and sheep. Reproduction in Domestic Animals 28(5): 258-262
Urdaneta, E.; Idoate, I.; Larralde, J. 1998: Drug-nutrient interactions: inhibition of amino acid intestinal absorption by fluoxetine. British Journal of Nutrition 79(5): 439-446
Barton, P.; Davis, A.M.; McCarthy, D.J.; Webborn, P.J. 1997: Drug-phospholipid interactions. 2. Predicting the sites of drug distribution using n-octanol/water and membrane/water distribution coefficients. Journal of Pharmaceutical Sciences 86(9): 1034-1039
Miranda, M.A.; Castell, J.V.; Hernández, D.; Gómez-Lechón, M.J.; Bosca, F.; Morera, I.M.; Sarabia, Z. 1998: Drug-photosensitized protein modification: identification of the reactive sites and elucidation of the reaction mechanisms with tiaprofenic acid/albumin as model system. Chemical Research in Toxicology 11(3): 172-177
Lin, S.Y.; Lee, C.J.; Lin, Y.Y. 1995: Drug-polymer interaction affecting the mechanical properties, adhesion strength and release kinetics of piroxicam-loaded Eudragit E films plasticized with different plasticizers. Journal of Controlled Release 33(3): 375-381
Gabor, F.; Pittner, F.; Spiegl, P. 1995: Drug-protein conjugates: Preparation of triamcinolone-acetonide containing bovine serum albumin/keyhole limpet hemocyanin-conjugates and polyclonal antibodies. Archiv der Pharmazie 328(11-12): 775-780
Chakravarty, S.; Kannan, K.K. 1994: Drug-protein interactions. Refined structures of three sulfonamide drug complexes of human carbonic anhydrase i enzyme. Journal of Molecular Biology 243(2): 298-309
Stephanos, J.J. 1996: Drug-protein interactions: Two-site binding of heterocyclic ligands to a monomeric hemoglobin. Journal of Inorganic Biochemistry 62(3): 155-169
Noto, A.-Regina; Carlini, E.A. 1995: Drug-provoked hospital admissions: An analysis of seven consecutive years (1987-1993). Revista ABP APAL (Associacao Brasileira de Psiquiatria Asociacion Psiquiatrica de la America Latina) 17(3): 107-114
Takayanagi, I.; Satoh, M.; Koike, K. 1993: Drug-receptor interactions in single smooth muscle cells. Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 101(3): 111-122
Stanton, L.A.; Peterson, G.M.; Rumble, R.H.; Cooper, G.M.; Polack, A.E. 1994: Drug-related admissions to an Australian hospital. Journal of Clinical Pharmacy and Therapeutics 19(6): 341-347
Llau, M.E.; Viraben, R.; Montastruc, J.L. 1995: Drug-related alopecia: A review. Therapie (Paris) 50(2): 145-150
Ben Noun, Liubov 1998: Drug-related asthma. Journal of Pharmacy Technology 14(3): 116-124
Celentano, D.D.; Muñoz, A.; Cohn, S.; Nelson, K.E.; Vlahov, D. 1994: Drug-related behavior change for HIV transmission among American injection drug users. Addiction 89(10): 1309-1317
Püschel, K. 1993: Drug-related death--an update. Forensic Science International 62(1-2): 121-128
Risser, D.; Schneider, B. 1994: Drug-related deaths between 1985 and 1992 examined at the Institute of Forensic Medicine in Vienna, Austria. Addiction 89(7): 851-857
Kaa, E.; Teige, B. 1993: Drug-related deaths during the 1980s. A comparative study of drug addict deaths examined at the institutes of forensic medicine in Aarhus, Denmark and Oslo, Norway. International Journal of Legal Medicine 106(1): 5-9
Drmic, I.; Gojanovic, M.D.; Vilovic, K.; Ivanovic, J.; Andelinovic, S. 1995: Drug-related deaths in Split, 1988-1994. Croatian Medical Journal 36(4): 278-281
Nelson, K.M.; Talbert, R.L. 1996: Drug-related hospital admissions. Pharmacotherapy 16(4): 701-707
Roughead, E.E.; Gilbert, A.L.; Primrose, J.G.; Sansom, L.N. 1998: Drug-related hospital admissions: a review of Australian studies published 1988-1996. Medical Journal of Australia 168(8): 405-408
Johnson, J.A.; Bootman, J.L. 1995: Drug-related morbidity and mortality. A cost-of-illness model. Archives of Internal Medicine 155(18): 1949-1956
Mittmann, N.; Liu, B.A.; Iskedjian, M.; Bradley, C.A.; Pless, R.; Shear, N.H.; Einarson, T.R. 1997: Drug-related mortality in Canada (1984-1994). Pharmacoepidemiology and Drug Safety 6(3): 157-168
Cunningham, G.; Dodd, T.R.; Grant, D.J.; McMurdo, M.E.; Richards, R.M. 1997: Drug-related problems in elderly patients admitted to Tayside hospitals, methods for prevention and subsequent reassessment. Age and Ageing 26(5): 375-382
Morin, B.; Oliva, V.L.; Lalonde, L.; Panzini, B.; Bourdon, F. 1995: Drug-related segmental colitis: Angiographic findings. Abdominal Imaging 20(6): 529-530
Eckardt, L.; Haverkamp, W.; Mertens, H.; Johna, R.; Clague, J.R.; Borggrefe, M.; Breithardt, G. 1998: Drug-related torsades de pointes in the isolated rabbit heart: comparison of clofilium, d,l-sotalol, and erythromycin. Journal of Cardiovascular Pharmacology 32(3): 425-434
Hasegawa, M.; Kobayashi, I.; Saika, T.; Nishida, M. 1997: Drug-resistance patterns of clinical isolates of Pseudomonas aeruginosa with reference to their lipopolysaccharide compositions. ChemoTherapy 43(5): 323-331
Riva Lavieille, C. 1994: Drug-resistance, oncogenes and tumor suppressor gene in squamous cell carcinomas. Bulletin du Cancer 81(Suppl 2): 105S-111S
Pineda-Garcia, L.; Ferrera, A.; Galvez, C.A.; Hoffner, S.E. 1997: Drug-resistant Mycobacterium tuberculosis and atypical mycobacteria isolated from patients with suspected pulmonary tuberculosis in Honduras. Chest 111(1): 148-153
Costa, P.; Gattuso, G.; Morandini, B.; Perboni, G.; Pinsi, A.R.ballo Gabriele; Scalzini, A. 1997: Drug-resistant Mycobacterium tuberculosis in Italy: An emerging issue. Giornale Italiano di Malattie Infettive 3(6): 363-366
Gottlieb, T. 1996: Drug-resistant Streptococcus pneumoniae: the beginning of the end for many antibiotics?. Medical Journal of Australia 165(4): 233-234
M.Mengchu 1997: Drug-resistant analysis of patients with bacillary dysentery. Acta Academiae Medicinae Hubei 18(2): 168-169
Gudas, J.M.; Nguyen, H.; Li, T.; Sadzewicz, L.; Robey, R.; Wosikowski, K.; Cowan, K.H. 1996: Drug-resistant breast cancer cells frequently retain expression of a functional wild-type p53 protein. Carcinogenesis 17(7): 1417-1427
Boivin, G. 1998: Drug-resistant herpesviruses: Should we look for them?. European Journal of Clinical Microbiology and Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 17(8): 539-541
Schaberg, T.; Gloger, G.; Reichert, B.; Mauch, H.; Lode, H. 1995: Drug-resistant pulmonary tuberculosis in Berlin, Germany, 1987-1993. European respiratory journal 8(2): 278-284
Fallon, P.G.; Doenhoff, M.J. 1994: Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific. American Journal of Tropical Medicine and Hygiene 51(1): 83-88
Ordway, D.J.; Sonnenberg, M.G.; Donahue, S.A.; Belisle, J.T.; Orme, I.M. 1995: Drug-resistant strains of Mycobacterium tuberculosis exhibit a range of virulence for mice. Infection and Immunity 63(2): 741-743
Bonforte, R.J.; Gribetz, I. 1971: Drug-resistant tuberculosis. New England Journal of Medicine 284(14): 795-796
Borchardt, J.; Kirsten, D.; Jörres, R.; Kroeger, C.; Magnussen, H. 1995: Drug-resistant tuberculosis in northern Germany: a retrospective hospital-based study of 1,055 patients from 1984 until 1993. European Respiratory Journal 8(7): 1076-1083
Grandes, G.; Lopez-de-Munain, J.; Diaz, T.; Rullan, J.V. 1993: Drug-resistant tuberculosis in Puerto Rico, 1987-1990. American Review of Respiratory Disease 148(1): 6-9
Yew, W.W.; Chau, C.H. 1995: Drug-resistant tuberculosis in the 1990s. European Respiratory Journal 8(7): 1184-1192
Vareldzis, B.P.; Grosset, J.; de Kantor, I.; Crofton, J.; Laszlo, A.; Felten, M.; Raviglione, M.C.; Kochi, A. 1994: Drug-resistant tuberculosis: laboratory issues. World Health Organization recommendations. Tubercle and Lung Disease: the Official Journal of the International Union Against Tuberculosis and Lung Disease 75(1): 1-7
Cohn, D., L.; Bustreo, F.; Raviglione, M., C. 1997: Drug-resistant tuberculosis: Review of the worldwide situation and the WHO/IUATLD Global Surveillance Project. Clinical Infectious Diseases 24(Suppl 1): S121-S130
Kai, T.; Bremerich, D.H.; Jones, K.A.; Warner, D.O. 1998: Drug-specific effects of volatile anesthetics on Ca2+ sensitization in airway smooth muscle. Anesthesia and Analgesia 87(2): 425-429
Katsutani, N.; Shionoya, H. 1992: Drug-specific immune responses induced by immunization with drugs in guinea pigs and mice. Journal of Toxicological Sciences 17(4): 169-183
Wettergren, Y.; Kullberg, A.; Levan, G. 1994: Drug-specific rearrangements of chromosome 12 in hydroxyurea-resistant mouse SEWA cells: Support for chromosomal breakage model of gene amplification. Somatic Cell and Molecular Genetics 20(4): 267-285
Borgnetto, M.E.; Zunino, F.; Tinelli, S.; Kas, E.; Capranico, G. 1996: Drug-specific sites of topoisomerase II DNA cleavage in Drosophila chromatin: heterogeneous localization and reversibility. Cancer Research 56(8): 1855-1862
Welker, E.; Szabó, K.; Holló, Z.; Müller, M.; Sarkadi, B.; Váradi, A. 1995: Drug-stimulated ATPase activity of a deletion mutant of the human multidrug-resistance protein (MDR1). Biochemical and Biophysical Research Communications 216(2): 602-609
Loo, T.W.; Clarke, D.M. 1997: Drug-stimulated ATPase activity of human P-glycoprotein requires movement between transmembrane segments 6 and 12. Journal of Biological Chemistry 272(34): 20986-20989
Scarborough, G.A. 1995: Drug-stimulated ATPase activity of the human P-glycoprotein. Journal of Bioenergetics and Biomembranes 27(1): 37-41
Szabó, K.; Welker, E.; Bakos; Müller, M.; Roninson, I.; Váradi, A.; Sarkadi, B. 1998: Drug-stimulated nucleotide trapping in the human multidrug transporter MDR1. Cooperation of the nucleotide binding domains. Journal of Biological Chemistry 273(17): 10132-10138
Viana, F.; Van Acker, K.; De Greef, C.; Eggermont, J.; Raeymaekers, L.; Droogmans, G.; Nilius, B. 1995: Drug-transport and volume-activated chloride channel functions in human erythroleukemia cells: Relation to expression level of P-glycoprotein. Journal of Membrane Biology 145(1): 87-98
Christophersen, A.S.; Mørland, J. 1997: Drugged driving, a review based on the experience in Norway. Drug and Alcohol Dependence 47(2): 125-135
Khadour, F.; Karim, K.; Najim, R. 1996: Drugs acting at central benzodiazepine receptors attenuate ethanol-induced gastric lesions in rats. European Journal of Pharmacology 298(3): 271-277
Berger, P.; Farrel, K.; Sharp, F.; Skolnick, P. 1994: Drugs acting at the strychnine-insensitive glycine receptor do not induce HSP-70 protein in the cingulate cortex. Neuroscience Letters 168(1-2): 147-150
Horváth, G.; Morvay, Z.; Kovács, M.; Szilágyi, A.; Szikszay, M. 1996: Drugs acting on calcium channels modulate the diuretic and micturition effects of dexmedetomidine in rats. Life Sciences 59(15): 1247-1257
Bevilaqua, L.; Ardenghi, P.; Schröder, N.; Bromberg, E.; Schmitz, P.K.; Schaeffer, E.; Quevedo, J.; Bianchin, M.; Walz, R.; Medina, J.H.; Izquierdo, I. 1997: Drugs acting upon the cyclic adenosine monophosphate/protein kinase a signalling pathway modulate memory consolidation when given late after training into rat hippocampus but not amygdala. Behavioural Pharmacology 8(4): 331-338
Boom, A.; Flamion, B.; Abramow, M.; Beauwens, R. 1995: Drugs activating G proteins disturb cycling of ADH-dependent water channels in toad urinary bladder. American Journal of Physiology 269(2 Part 1): C424-C434
Ma, L.; Michel, W.C. 1998: Drugs affecting phospholipase C-mediated signal transduction block the olfactory cyclic nucleotide-gated current of adult zebrafish. Journal of Neurophysiology 79(3): 1183-1192
Belen'kaya, I.A.; Sirik, S.A. 1994: Drugs among pesticides (a review). Khimiko Farmatsevticheskii Zhurnal 28(5): 20-25
Pihl, R.O.; Peterson, J. 1995: Drugs and aggression: correlations, crime and human manipulative studies and some proposed mechanisms. Journal of Psychiatry and Neuroscience: Jpn 20(2): 141-149
Poshyachinda, V. 1993: Drugs and aids in southeast-Asia. Forensic Science International 62(1-2): 15-28
Augsburger, M.; Rivier, L. 1997: Drugs and alcohol among suspected impaired drivers in Canton de Vaud (Switzerland). Forensic Science International 85(2): 95-104
Thomas, J.A. 1998: Drugs and chemicals that affect the endocrine system. International Journal of Toxicology 17(2): 129-138
Friedman, G.D.; Coates, A.O.; Potter, J.D.; Slattery, M.L. 1998: Drugs and colon cancer. Pharmacoepidemiology and Drug Safety 7(2): 99-106
Brignoli, R.; Meier, R.; Miazza, B. 1993: Drugs and determination of gastrointestinal motility. Schweizerische Medizinische Wochenschrift Suppl 1993(54): 45-54
Colburn, W.A. 1994: Drugs and endogenous ligands compete for receptor occupancy. Journal of Clinical Pharmacology 34(12): 1148-1152
Cabral, G.A.; Dove Pettit, D.A. 1998: Drugs and immunity: cannabinoids and their role in decreased resistance to infectious disease. Journal of Neuroimmunology 83(1-2): 116-123
Tønnesen, H.H. 1997: Drugs and light. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 117(17): 2481-2483
Wittbrodt, E.T. 1997: Drugs and myasthenia gravis. An update. Archives of Internal Medicine 157(4): 399-408
Thomas, Simon, H.L. 1997: Drugs and the QT interval. Adverse Drug Reaction Bulletin 1997(182): 691-694
Thomson, N.M. 1995: Drugs and the kidney in the elderly. Medical Journal of Australia 162(10): 543-547
Smart, R.G.; Mann, R.E.; Tyson, L.A. 1997: Drugs and violence among Ontario students. Journal of Psychoactive Drugs 29(4): 369-373
Testa, B. 1997: Drugs as chemical messages: Molecular structure, biological context, and structure-activity relationships. Medicinal Chemistry Research 7(6-7): 340-365
Cuena Roy, R. 1997: Drugs as teratogenic agents: Principles for pharmacotherapy during pregnancy. Farmacia Clinica 14(7): 450-457
Bastuji-Garin, S.; Joly, P.; Picard-Dahan, C.; Bernard, P.; Vaillant, L.; Pauwels, C.; Salagnac, V.; Lok, C.; Roujeau, J.C. 1996: Drugs associated with bullous pemphigoid. A case-control study. Archives of Dermatology 132(3): 272-276
Hammersley, R.; Cassidy, M.T.; Oliver, J. 1995: Drugs associated with drug-related deaths in Edinburgh and Glasgow, November 1990 to October 1992. Addiction 90(7): 959-965
Fernandez Hervas, M.J.; Holgado, M.A.; Rabasco, A.M. 1997: Drugs colon as a site of drug delivery. Ciencia Pharmaceutica 7(4): 161-169
Sanchez\$paya, J.; Romo-Cortina, T.; Rodriguez-Ortiz-De-Salazar, B.; Barrio-Anta, G. 1991: Drugs consumption in Spain: Information sources and evolution during the period 1984-1990. Revista de Sanidad e Higiene Publica 65(5): 395-412
Steiner, A.; Roussel, A.J. 1995: Drugs coordinating and restoring gastrointestinal motility and their effect on selected hypodynamic gastrointestinal disorders in horses and cattle. Zentralblatt für Veterinarmedizin. Reihe a 42(10): 613-631
Chanalet, L.; Lapalus, P. 1994: Drugs designed to maintain the transparence of the ocular lens. Fundamental and Clinical Pharmacology 8(4): 322-341
Lip, G.Y.H.; Watson, R.D.S.; Singh, S.P. 1995: Drugs for atrial fibrillation. British Medical Journal 311(7020): 1631-1634
Kreuzfeld, H.J.; Boebler, C.; Schmdit, U.; Krause, H.W. 1998: Drugs for chiral discrimination: Non-coded amino acids and dipeptides by asymmetric hydrogenation. Chirality 10(6): 535-539
Vilardi, V.; Capotosto, S. 1997: Drugs for miorisolution: Their characteristics and indications for their use in operating-room and reenimation. Acta Anaesthesiologica Italica 48(3-4): 77-100
Brunner, G.; Luna, P.; Thiesemann, C. 1995: Drugs for pH control in upper gastrointestinal bleeding. Alimentary Pharmacology and Therapeutics 9(Suppl): 47-50